adenosine monophosphate has been researched along with Pneumonia, Viral in 251 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 251 (100.00) | 2.80 |
Authors | Studies |
---|---|
Almario-Hernandez, AF; Doerholt, K; Drysdale, SB; Gilmour, C; Heath, PT; Pereira, NMD | 1 |
Ferrara, F; Trama, U; Vitiello, A; Zovi, A | 1 |
Addo, MM; Aepfelbacher, M; Fischer, N; Grundhoff, A; Günther, T; Heyer, A; Jarczak, D; Kluge, S; Lütgehetmann, M; Robitaille, A; Schulze Zur Wiesch, J | 1 |
Lu, H | 1 |
Cao, R; Hu, Z; Liu, J; Shi, Z; Wang, M; Xiao, G; Xu, M; Yang, X; Zhang, L; Zhong, W | 1 |
Cihlar, T; Cronin, J; de Wit, E; Feldmann, F; Feldmann, H; Jordan, R; Okumura, A; Scott, D; Thomas, T | 1 |
Maxmen, A | 1 |
Lu, X; Pan, B; Sun, P; Sun, W; Xu, C | 1 |
Li, J; Qi, C; Shen, L; Wang, Y; Zhang, Q | 1 |
Elfiky, AA | 1 |
De Clercq, E; Li, G | 1 |
Anderson, PO | 1 |
Brouqui, P; Colson, P; Lagier, JC; Raoult, D; Rolain, JM | 1 |
Chen, PL; Hsueh, PR; Huang, CT; Ko, WC; Lee, NY; Lee, PI; Rolain, JM | 1 |
Dong, L; Gao, J; Hu, S | 1 |
Martinez, MA | 2 |
Du, B; Kang, HYJ; Li, XY; Qiu, HB; Sun, B; Tong, ZH; Wang, F; Wang, YS; Zhan, X | 1 |
Hsueh, PR; Hsueh, SC; Ko, WC; Lai, CC; Liu, YH; Wang, CY; Wang, YH; Yen, MY | 1 |
Duan, Y; Zhou, C; Zhu, HL | 1 |
Carradori, S | 1 |
Atluri, S; Hirsch, JA; Manchikanti, L | 1 |
Cohen, J; Kupferschmidt, K | 1 |
Reina, J | 1 |
Ceccarelli, F; Conti, F; Di Franco, M; Spinelli, FR | 1 |
Chang, YL; Chen, MY; Lee, WS; Lu, CC | 1 |
Chan, MCW; Chen, D; Cheung, PP; Choy, KT; Chu, DKW; Huang, X; Hui, KPY; Kaewpreedee, P; Peiris, M; Sia, SF; Wong, AY; Yen, HL | 1 |
Agostini, ML; Baric, RS; Bluemling, GR; Brown, AJ; Chappell, JD; Denison, MR; Dinnon, KH; George, AS; Graham, RL; Harcourt, J; Hill, CS; Hughes, TM; Kolykhalov, AA; Leist, SR; Lu, X; Montgomery, SA; Natchus, MG; Painter, G; Pruijssers, AJ; Saindane, M; Schäfer, A; Sheahan, TP; Sims, AC; Stevens, LJ; Swanstrom, R; Tamin, A; Thornburg, NJ; Zhou, S | 1 |
Barlow, A; Barlow, B; Claassen, CW; Heavner, JJ; Heavner, MS; Landolf, KM; Yeung, SYA | 1 |
Ahmed, S; Asperges, E; Bernett, J; Brainard, DM; Cao, H; Castagna, A; Chelliah, D; Chen, D; Chihara, S; Childs, R; Chokkalingam, A; Cohen, SH; Cunningham, J; D'Arminio Monforte, A; Desai, P; DeZure, A; Diaz, G; Elboudwarej, E; Feldt, T; Flanigan, T; Gaggar, A; Green, G; Green, ML; Grein, J; Henne, I; Ismail, S; Kato, H; L'Her, E; Lapadula, G; Lescure, FX; Maeno, T; Majumder, S; Massari, M; Mera, R; Mora-Rillo, M; Mutoh, Y; Myers, RP; Nguyen, D; Nicastri, E; Oda, R; Ohmagari, N; Osinusi, AO; Quiros-Roldan, E; Redinski, J; Sellers, S; Shin, D; Studemeister, A; Tan, SK; Telep, L; Timbs, L; Verweij, E; Winterbourne, L; Yo, K; Zhao, Y; Zhong, L; Zoufaly, A | 1 |
Bottega, A; da Rosa, TF; Foletto, VS; Hörner, A; Hörner, R; Serafin, MB | 1 |
Belfer, JJ; Bondici, A; Dumkow, LE; Hillaker, E; Murad, H | 1 |
Cutrell, JB; Jodlowski, TZ; Monogue, ML; Sanders, JM | 1 |
Arora, N; Banerjee, AK | 1 |
Avery, RK; Boyarsky, BJ; Durand, CM; Garonzik-Wang, JM; Getsin, SN; Jackson, KR; Kernodle, AB; Massie, AB; Po-Yu Chiang, T; Segev, DL; Van Pilsum Rasmussen, SE; Werbel, WA | 1 |
Alvarez, K; Canard, B; Decroly, E; Eydoux, C; Ferron, F; Guillemot, JC; Le, NT; Peersen, O; Selisko, B; Shannon, A | 1 |
Şimşek Yavuz, S; Ünal, S | 1 |
Costanzo, M; De Giglio, MAR; Roviello, GN | 1 |
Lal, A; Mishra, AK; Sahu, KK | 1 |
Bergan, S; Elens, L; Hesselink, DA; Langman, LJ; Lemaitre, F; Moes, DJAR; Molinaro, M; Venkataramanan, R | 1 |
Gangadaran, P; Jogalekar, MP; Veerabathini, A | 1 |
Hsueh, PR; Jean, SS; Lee, PI | 1 |
Al-Saffar, F; Cruz, D; Fan, A; Gaynor, P; Hsu, JJ; Kamath, M; Nsair, A | 1 |
Aryal, D; Beane, A; Dondorp, AM; Hayat, M; Schultz, MJ | 1 |
Ge, J; Li, H; Liu, Z | 1 |
Aronson, JK; Ferner, RE | 1 |
Beard, T; Cowan, M; Manning, TJ; Thomas-Richardson, J | 1 |
Aaron, JG; Arcasoy, S; Aversa, MM; Benvenuto, LJ; Brown, RS; Cohen, DJ; Dadhania, DM; Dove, LM; Dube, GK; Emond, JC; Farr, MA; Husain, SA; Kapur, S; Kodiyanplakkal, RP; Miko, BA; Mohan, S; Pereira, MR; Ratner, LE; Rosenblatt, RE; Samstein, B; Satlin, M; Small, CB; Tsapepas, DS; Uriel, N; Verna, EC; Walsh, TJ | 1 |
Ledford, H | 4 |
Augustin, M; Hallek, M; Nitschmann, S | 2 |
Alkindi, N; Mazer-Amirshahi, M; Mehta, N; Pourmand, A | 1 |
Ahsan, W; Alhazmi, HA; Bratty, MA; Javed, S; Najmi, A | 1 |
Ardura, M; Auletta, JJ; Dandoy, C; Hartley, D; Jaglowski, S; Lehmann, L | 1 |
Kao, JH; Su, TH | 1 |
Jeevaratnam, K | 1 |
Dai, J; Huang, J; Jiang, H; Li, C; Li, R; Li, X; Liu, B; Ma, Q; Pan, W; Shi, Y; Wang, Z; Xie, Y; Yang, Z; Zhao, J; Zheng, K | 1 |
Antonucci, M; Avataneo, V; Cusato, J; D'Avolio, A; de Nicolò, A; di Perri, G; Lamorde, M; Manca, A; Palermiti, A; Waitt, C; Walimbwa, S | 1 |
Delang, L; Neyts, J | 1 |
Ballout, RA; Bukrinsky, MI; Remaley, AT; Sviridov, D | 1 |
Fang, Y; Meng, XM; Ni, WJ; Shen, AZ; Xu, T; Zhou, H | 1 |
Cao, D; Li, C; Li, G; Li, Z; Sun, R; Wang, X | 1 |
Baden, LR; Morrissey, S; Rubin, EJ | 4 |
Kiessling, L; MacLaughlin, C; Sattin, S | 1 |
Douedi, S; Miskoff, J | 1 |
Coumou, J; de Vries, PJ | 1 |
Gadebusch Bondio, M; Marloth, M | 1 |
Anastasiou, IA; Eleftheriadou, I; Tentolouris, A; Tentolouris, N; Tsilingiris, D | 1 |
Baggett, MV; Rhee, EP; Shepard, JO; Sise, ME; Stevens, JS | 1 |
Ferguson, J; Gumma, M; Kappagoda, S; Quintero, O; Rogers, A; Rosser, JI; Scott, J; Subramanian, A | 1 |
Boucher, HW; Ison, MG; Wolfe, C | 1 |
Aldrich, M; Cabana, MD; Chao, JY; Derespina, KR; Goldman, DL; Herold, BC; Medar, SS; Ushay, HM; Weingarten, J | 1 |
Angeli, E; Antinori, S; Bonazzetti, C; Borghi, B; Castelli, A; Coen, M; Colombo, R; Corbellino, M; Cossu, MV; Galli, M; Giacomelli, A; Giorgi, R; Gismondo, MR; Gubertini, G; Magni, C; Meroni, L; Milazzo, L; Mileto, D; Oreni, L; Pagani, G; Pellicciotta, M; Rech, R; Ridolfo, AL; Rizzardini, G; Rusconi, S; Torre, A; Vimercati, S | 1 |
Bonovas, S; Piovani, D | 1 |
Fätkenheuer, G; Lundgren, J | 1 |
Hoffmann, C | 1 |
Lai, T; Wu, B; Wu, J | 1 |
Brainard, D; Grein, J; Myers, RP | 1 |
Andini, R; Bertolino, L; Corcione, A; Durante-Mangoni, E; Florio, LL; Mele, F; Murino, P; Zampino, R | 1 |
Jia, X; Kai, G; Li, L; Nile, A; Nile, SH; Qiu, J | 1 |
Stuebe, A | 1 |
Carugati, M; Castaldo, G; Faccioli, P; Franzetti, M; Iemoli, E; Longoni, E; Molteni, C; Ormas, V; Pandolfo, A; Piconi, S; Pozzetti, U | 1 |
Estella, Á; Garnacho-Montero, J | 1 |
Norrie, JD | 1 |
Cao, B; Cao, L; Cheng, Z; Ding, D; Du, G; Du, R; Fan, G; Fu, S; Gao, L; Gu, X; Guo, T; Hayden, FG; Horby, PW; Hu, Y; Jaki, T; Jiang, Y; Jin, Y; Li, H; Liu, B; Liu, Z; Lu, Q; Lu, Y; Luo, G; Mei, C; Qin, H; Ruan, S; Shang, L; Tang, X; Wan, Y; Wang, A; Wang, C; Wang, K; Wang, S; Wang, Y; Wu, F; Xu, J; Yang, C; Yang, J; Ye, X; Ye, Y; Yin, W; Zhang, D; Zhang, Y; Zhao, J; Zhou, F | 1 |
Marto, N; Monteiro, EC | 1 |
Aggarwal, G; Aggarwal, S; Bangalore, S; Henry, BM | 1 |
Cattaneo, D; Clementi, E; Corbellino, M; Galli, M; Gervasoni, C; Riva, A | 1 |
Ahmad, SI | 1 |
Gottlieb, M; Hicks, C; Liang, SY; Long, B; Rosenberg, H | 1 |
Bhattacharya, M; Chakraborty, C; Lee, SS; Saha, A; Sharma, AR; Sharma, G | 1 |
Atmar, RL; Babiker, AG; Beigel, JH; Benfield, T; Bonnett, T; Burgess, TH; Chu, HY; Creech, CB; Dierberg, K; Dodd, LE; Fätkenheuer, G; Finberg, RW; Green, M; Hohmann, E; Hsieh, L; Kalil, AC; Kline, S; Kortepeter, MG; Lane, HC; Lopez de Castilla, D; Luetkemeyer, A; Lundgren, J; Lye, DC; Makowski, M; Mehta, AK; Nayak, S; Neaton, JD; Oh, MD; Ohmagari, N; Osinusi, A; Paredes, R; Patterson, TF; Pett, S; Ruiz-Palacios, GM; Short, WR; Sweeney, DA; Tapson, V; Tomashek, KM; Touloumi, G; Zingman, BS | 1 |
Dresser, LD; Jorgensen, SCJ; Kebriaei, R | 1 |
Cao, B; Cheng, Z; Du, G; Du, R; Fan, G; Fu, S; Gao, L; Hayden, FG; Horby, PW; Hu, Y; Jaki, T; Jin, Y; Liu, W; Liu, Y; Lu, Q; Lu, Y; Luo, G; Ruan, S; Wang, C; Wang, K; Wang, Y; Zhang, D; Zhang, Y; Zhao, J; Zhou, F | 1 |
Sun, D | 1 |
Dolin, R; Hirsch, MS | 1 |
Ahn, MY; Blair, C; Brainard, DM; Bruno, R; Cao, H; Chen, YS; Diaz, G; Gaggar, A; Galli, M; Goldman, JD; Hui, DS; Hyland, RH; Lye, DCB; Marks, KM; Marty, FM; Montejano, R; Mullane, KM; Muñoz, J; Nahass, RG; Osinusi, AO; SenGupta, D; Spinner, CD; Subramanian, A; Tashima, KT; Towner, WJ; Wei, X | 1 |
Davies, M; Dhanda, S; Evans, A; Lane, S; Osborne, V; Roy, D; Shakir, S | 1 |
Jain, S; Jolly, T; Mansuri, Z; Shah, B; Zafar, MK | 1 |
Beh, DLL; Chew, N; Ngiam, JN; Poh, KK; Sia, CH | 1 |
Gupta, P; Kumar, A; Narasimha Kumar, GV; Prajapati, S; Sharma, M | 1 |
Bohula, EA; Lang, JP; Morrow, DA; Moura, FA; Siddiqi, HK; Wang, X | 1 |
Campos, L; Gouveia, CC | 1 |
Balevic, SJ; Benjamin, DK; Cohen-Wolkowiez, M; Gonzalez, D; Hornik, CD; Hornik, CP; Maharaj, AR; Smith, PB; Wu, H; Zimmerman, KO | 1 |
Andreou, A; Filippou, D; Sipsas, N; Trantza, S; Tsiodras, S | 1 |
Amore, A; Bimonte, S; Cascella, M; Celentano, E; Crispo, A; Cuomo, A | 1 |
Gebrie, D; Getnet, D; Manyazewal, T | 1 |
Islam, T; Nasir, M; Parveen, RA; Saha, SK; Selina, F; Talha, KA | 1 |
Adamsick, ML; Bhattacharyya, RP; Bidell, MR; Elshaboury, RH; Gandhi, RG; Kim, AY; Nigwekar, S; Rhee, EP; Sise, ME | 1 |
Benfiels, T; Jensen, TØ; Johansen, IS; Lundgren, J; Nielsen, H; Wiese, L; Østergaard, L | 1 |
Anzick, S; Barbian, K; Bosio, CM; Cihlar, T; de Wit, E; Feldmann, F; Hanley, PW; Leighton, I; Lovaglio, J; Martens, C; Meade-White, K; Munster, VJ; Okumura, A; Pérez-Pérez, L; Porter, DP; Saturday, G; Schulz, J; Schwarz, B; Scott, DP; van Doremalen, N; Williamson, BN; Yinda, CK | 1 |
Fumeaux, T | 1 |
Asudani, D; Bouland, D; Gupta, V; Kwak, K; Segar, S; Taplitz, R; Torriani, F | 1 |
Chen, D; Dong, L; Pan, X; Peng, C; Yang, L | 1 |
Di Perri, G | 1 |
Yoo, JH | 1 |
Bamford, A; Brierley, J; Frauenfelder, C; Perucca, G; Whittaker, E | 1 |
Di Pasquale, G; Maggioni, AP | 1 |
Abrams-Downey, A; Saabiye, J; Vidaurrazaga, M | 1 |
Hui, N; Li, H; Liang, C; Liu, Y; Qiao, G; Shi, Z; Tang, Y; Tian, L; Xie, X; Zhang, D; Zhao, X | 1 |
Ahn, BY; Choe, PG; Kang, CK; Kim, NJ; Oh, MD; Park, SW; Park, WB; Seo, JD; Song, SH | 1 |
Chan, R; Kuo, CR; Lipworth, B | 1 |
Besari, A; Lee, YY; Omar, SFS; Thalha, AMM | 1 |
Magro, G | 1 |
Alvarez, JC; Annane, D; Etting, I; Larabi, IA; Moine, P | 1 |
Gafarova, AR; Gainullina, EN; Timerbulatov, SV; Timerbulatov, VM; Timerbulstov, MV | 1 |
Angus, DC; White, DB | 1 |
Kaltenboeck, A; Kesselheim, AS; Sarpatwari, A | 1 |
Cooke, G; Costelloe, CE; Daunt, A; Hauck, K; Liew, F; Nayagam, S; Perez-Guzman, PN; Thursz, MR | 1 |
Cao, H; Chng, E; German, P; Humeniuk, R; Ling, J; Mathias, A; Osinusi, A; Shen, G; Vu, A | 1 |
Li, C; Ren, L; Wang, L | 1 |
Brandt, N; Chou, J | 1 |
Amenta, F; Nittari, G; Pallotta, G; Tayebati, SK | 1 |
Agrati, C; Ascoli Bartoli, T; Avataneo, V; Capobianchi, MR; Caputi, P; Castilletti, C; D'Avolio, A; Forini, O; Ippolito, G; Lalle, E; Marchioni, L; Nicastri, E; Notari, S; Scorzolini, L; Tempestilli, M | 1 |
Abraham, OC; John, R; Karthik, R; Manesh, A; Varghese, GM | 1 |
Ali, A; Ali, SS; Babar, Z; Hamayun, F; Khan, A; Khan, AA; Khan, M; Saleem, S; Sardar, Z; Wei, DQ | 1 |
Burwick, RM; Glucksman, L; Naqvi, M; Smithson, S; Zakowski, P | 1 |
Bouadma, L; Deconinck, L; Dubert, M; Ghosn, J; Houhou-Fidouh, N; Isernia, V; Kramer, L; Le Hingrat, Q; Le Pluart, D; Lescure, FX; Patrier, J; Rioux, C; Visseaux, B; Wicky, PH; Yazdanpanah, Y | 1 |
Azmy, V; Benson, J; Love, K; Steele, R | 1 |
Chakraborty, A; Hosoki, K; Sur, S | 1 |
Danta, CC | 1 |
Agostinis, P; Carafoli, E; Li, X; Melino, G; Rabson, A; Shi, Y; Sun, E; Wang, Y | 1 |
Cleland, E; Giovane, RA; Henderson, CE; Rezai, S | 1 |
Gillenwater, S; Hadeh, A; Rahaghi, F | 1 |
McMahon, JH; Peleg, AY; Udy, A | 1 |
Kim, DH; McCaw, ZR; Wei, LJ | 1 |
Olalla, J | 1 |
Beigel, JH; Dodd, LE; Tomashek, KM | 1 |
Ancliff, P; Badle, S; Bamford, A; Bartram, J; Brierley, J; Cheng, D; Dalton, C; Dexter, D; Dixon, G; Du Pré, P; Ghorashian, S; Grandjean, L; Mittal, P; O'Connor, D; Orf, K; Pavasovic, V; Rao, A; Rogosic, S; Samarasinghe, S; Vora, A | 1 |
Abi Jaoude, J; El Alam, MB; Garcia Garcia, CJ; Kouzy, R; Ludmir, EB; Taniguchi, CM | 1 |
Allen, JM; Bakare, LS | 1 |
Dizaye, K; Marouf, BH | 1 |
Brun, P; Dubois, J; Dulière, V; Julien, T; Lina, B; Padey, B; Pizzorno, A; Rosa-Calatrava, M; Terrier, O; Traversier, A | 1 |
Li, Z; Liu, Y; Wang, D | 1 |
Donato, AA; Paladugu, S | 1 |
Foo, R; Thum, T; Wang, Y | 1 |
Azevedo, PCP; Azevedo, TCP; Barbosa, FT; Carvalho, ARVS; Cezarotti Filho, ML; Matos-Rocha, TJ; Ramos, FWDS; Silveira Filho, RN; Sousa-Rodrigues, CF | 1 |
Arcobello, J; Bakouny, Z; Choueiri, TK; de Lima Lopes, G; Doroshow, DB; Egan, PC; Farmakiotis, D; Fecher, LA; Friese, CR; Galsky, MD; Goel, S; Grivas, P; Gupta, S; Halfdanarson, TR; Halmos, B; Hawley, JE; Hsu, CY; Khaki, AR; Kuderer, NM; Lee, BJ; Lemmon, CA; Lyman, GH; Mishra, S; Olszewski, AJ; Painter, CA; Panagiotou, OA; Pennell, NA; Peters, S; Puc, MM; Revankar, SG; Rini, BI; Rivera, DR; Rubinstein, SM; Schapira, L; Schmidt, A; Schwartz, GK; Shah, DP; Shah, SA; Shyr, Y; Thompson, MA; Warner, JL; Wu, JT; Xie, Z; Yeh, AC; Zhu, H | 1 |
Helleberg, M; Kirk, O; Lane, C; Lebech, AM; Lundgren, J; Moestrup, KS; Niemann, CU | 1 |
Albrecht, R; Benner, C; Burgstaller-Muehlbacher, S; Cao, J; Chan, JF; Chanda, SK; Chang, MW; Chapman, ME; Chatterjee, AK; Cheng, K; Choi, A; De Jesus, PD; Dejosez, M; García-Sastre, A; Glynne, RJ; Herbert, KM; Hull, MV; Johnson, JR; Lendy, EK; Liu, WC; Martin-Sancho, L; Martinez-Sobrido, L; Matsunaga, N; Mesecar, AD; Miorin, L; Nguyen, C; Nguyen, TH; Pache, L; Poon, VK; Pu, Y; Rathnasinghe, R; Riva, L; Rubanov, A; Ruppin, E; Schotsaert, M; Schultz, PG; Sit, KY; Su, AI; Sun, R; Teriete, P; White, KM; Yin, X; Yuan, S; Yuen, KY; Zwaka, TP | 1 |
Bellutti-Enders, F; Hartmann, K; Jamiolkowski, D; Leuppi-Taegtmeyer, A; Manjaly Thomas, ZR; Scherer Hofmeier, K; Steveling-Klein, E | 1 |
Carvalho Junior, RN; J C Neto, AM; Martins, AY; Reis, AF; S Costa, JF; Silva Arouche, TD | 1 |
Durrieu, G; Montastruc, F; Thuriot, S | 1 |
Abd Ellah, NH; E Batiha, G; Gad, SF; Hetta, HF; Muhammad, K | 1 |
Andini, R; Bertolino, L; Corcione, A; De Rosa, R; Durante-Mangoni, E; Florio, LL; Galdo, M; Mele, F; Zampino, R | 1 |
Aly, B; Baron, DA; Blodget, E; Hashemi, A; Kouyoumjian, S; Musa, A; Pendi, K; Stevens, S; Warbasse, E; Yousif, J | 1 |
Martín Mateos, RM; Téllez, L | 1 |
Kääb, S; Kellnar, A; Stark, K; Stremmel, C; Weckbach, LT | 1 |
Agarwal, A; Agoritsas, T; Azab, M; Bartoszko, JJ; Bravo, G; Brignardello-Petersen, R; Chu, DK; Couban, R; Devji, T; Escamilla, Z; Foroutan, F; Gao, Y; Ge, L; Ghadimi, M; Guyatt, GH; Han, MA; Heels-Ansdell, D; Honarmand, K; Hou, L; Ibrahim, Q; Izcovich, A; Khamis, A; Kum, E; Lam, B; Lamontagne, F; Loeb, M; Mansilla, C; Marcucci, M; Martinez, JPD; McLeod, SL; Miroshnychenko, A; Motaghi, S; Murthy, S; Mustafa, RA; Pardo-Hernandez, H; Qasim, A; Rada, G; Rizwan, Y; Saadat, P; Siemieniuk, RA; Switzer, C; Thabane, L; Tomlinson, G; Vandvik, PO; Vernooij, RW; Viteri-García, A; Wang, Y; Yao, L; Zeraatkar, D; Zhao, Y | 1 |
Agarwal, A; Agoritsas, T; Appiah, JA; Bartoszko, J; Brignardello-Petersen, R; Ergan, B; Ge, L; Geduld, H; Gershengorn, HB; Guyatt, G; Huang, M; Kanda, S; Kawano-Dourado, L; Kurian, L; Kwizera, A; Lamontagne, F; Leo, YS; Manai, H; Murthy, S; Qadir, N; Rochwerg, B; Siemieniuk, R; Silvestre, MA; Vandvik, PO; Ye, Z; Zeng, L; Zeraatkar, D | 1 |
Saitz, R; Schwitzer, G | 1 |
Bu, Z; Ge, J; He, X; Hua, R; Liu, R; Shan, D; Shuai, L; Sun, Z; Wang, C; Wang, J; Wang, X; Wen, Z; Zhang, X; Zhong, G | 1 |
Baombe, JP | 1 |
Mendes, A | 1 |
Li, N; Li, Y; Yu, X | 1 |
Gan, W; Gu, J; Li, H; Li, Y; Lu, C; Luo, P; Miao, H; Tian, M; Wang, J; Wang, S; Wu, M; Yao, Y; Yuan, B; Zhao, D; Zhao, X | 1 |
Aziz, N; Bianco, K; Blackburn, BG; El-Sayed, YY; Grant, P; Igbinosa, I; Kappagoda, S; Lyell, DJ; Miller, S; Nelson, J; Subramanian, A | 1 |
Al-Yamani, MJ; Asdaq, SMB; Jomah, S | 1 |
Ijaz, M; Khan, M; Kharaba, ZJ; Murtaza, G; Shamim, S | 1 |
Bugiera, L; Grodd, M; Hazard, D; Kaier, K; Lambert, J; von Cube, M; Wolkewitz, M | 1 |
Bigley, AN; Narindoshvili, T; Raushel, FM | 1 |
Alvaro-Gracia, JM; Blanco, R; Carmona, L; Castrejón, I; Fernández Fernández, D; Fernandez-Nebro, A; Galindo, M; Gonzalez-Gay, MA; Lledó, A; Manrique-Arija, S; Martinez-Lopez, D; Mena Vázquez, N; Mera-Varela, A; Pablos, JL; Retuerto, M | 1 |
Chua, KP; Conti, RM | 1 |
Baysson, H; Beaune, G; Bing, F; Bonardel, C; Bonnerot, M; Chanzy, B; Combes, I; Cornut, L; Farines, M; Ludwig, M; Macheda, G; Vadot, W | 1 |
Hadda, V; Misra, S; Nath, M; Vibha, D | 1 |
Farhadi, T; Hashemian, SM; Velayati, AA | 1 |
Angus, DC; McCreary, EK | 1 |
Ahn, MY; Arribas López, JR; Bernasconi, E; Bhagani, S; Blair, C; Brainard, DM; Cao, H; Castagna, A; Cattelan, AM; Chai, LYA; Chang, SC; Criner, GJ; Gaggar, A; Gottlieb, RL; Huhn, G; Hyland, RH; Le Turnier, P; Malhotra, P; Marty, FM; McPhail, MJ; Mullane, KM; Ogbuagu, O; Osinusi, AO; Roestenberg, M; Sanyal, AJ; SenGupta, D; Soriano Viladomiu, A; Spinner, CD; Tsang, OTY; Wang, H | 1 |
Briasoulis, A; Kuno, T; Takagi, H; Yokoyama, Y | 1 |
Barchiesi, F; Canovari, B; Mancini, M; Montalti, R; Pasquini, Z; Pimpini, D; Temperoni, C; Tempesta, M; Zallocco, N | 1 |
Bliton, MJ; Weber, E | 1 |
Adewale, OB; Akanbi, MO; Bakare, OO; Fadaka, AO; Klein, A; Madiehe, AM; Meyer, M; Sibuyi, NRS | 1 |
Barfuss, P; Demirbag, S; Khan, KS; Le, TK; Ng, WL; Paris, C; Robson, F; Rocchi, P | 1 |
Baker, JV; DeBruin, DA; Kesler, S; Kline, S; Leider, JP; Lim, S; Lynfield, R; Rizza, S; Sederstrom, N; Sharp, RR; Wolf, SM; Wu, J | 1 |
Filipova, E; Pavlova, V; Uzunova, K; Vekov, T | 1 |
Bhagani, S; Pollara, G; Richardson, C | 1 |
Shih, WJ; Xie, T; Yao, C | 1 |
Bunel, V; Descamps, D; Jaquet, P; Le Hingrat, Q; Lê, MP; Mal, H; Massias, L; Messika, J; Peytavin, G; Timsit, JF; Visseaux, B; Wicky, PH | 1 |
Lamb, YN | 1 |
Kay, AW; Mandalakas, AM; Martinez, L; Ness, TE | 1 |
Gonzales-Zamora, JA; Quiroz, T; Vega, AD | 1 |
Green, RJ; Mustafa, F; Richards, GA; Sewlall, N | 1 |
Dobrovolny, HM | 1 |
Doggrell, SA | 1 |
Gohh, R; Merhi, B | 1 |
Hasslboeck, C; Kishioka, Y; Kweder, SL; Saint-Raymond, A; Sato, J; Teixeira, T | 1 |
Arthur, CM; Clarke, S; Josephson, CD; Lough, C; MacDonald, H; Roback, JD; Rodriguez, Z; Shane, AL; Stowell, SR; Suthar, M; Verkerke, H; Wolf, M; Wrammert, J; Zimmerman, MG | 1 |
Shilatifard, A | 1 |
Hansen, PR; Jürgens, G; Rasmussen, HB; Taboureau, O; Thomsen, R | 1 |
Ader, F | 1 |
Gupta, SP | 1 |
Alshaeri, HK; Natto, ZS | 1 |
Bai, YX; Guo, Y; Ma, KW; Qiu, S; Sun, C; Wang, X; Xu, YH | 1 |
Perišić, O | 1 |
Ata, O; Inci, TG; Kocer, S; Mutlu, O; Sariyer, E; Turgut-Balik, D; Ugurel, E; Ugurel, OM | 1 |
Emanuela, C; Francesco, L; Giorgia, G; Pasquale, N; Roberto, P; Sara, D | 1 |
Dzhafer, N; Papathanasiou, JV | 1 |
Glaus, MJ; Von Ruden, S | 1 |
Adimora, AA; Cole, SR; Edwards, JK | 1 |
Cui, JJ; Guo, CX; Ouyang, QY; Wang, LY; Yin, JY; Zhan, Y | 1 |
Cao, B; Gu, X; Wang, C; Wang, Y; Xu, J | 1 |
Gómez-Moreno, G | 1 |
Chien, M; Jockusch, S; Ju, J; Kalachikov, S; Kumar, S; Li, X; Morozova, I; Russo, JJ; Tao, C | 1 |
Goldust, M; Sandhu, S; Schwartz, RA; Sharma, A; Szepietowski, JC | 1 |
Fätkenheuer, G; Malin, JJ; Priesner, V; Rybniker, J; Suárez, I | 1 |
Gupta, J; Gupta, S; Kaushik, A | 1 |
Garg, NK; Knapp, RR; Okada, T; Sarpong, R; Tona, V | 1 |
Ali, K; Mallah, H; Maveddat, A; Nugent, K; Rao, S; Sherali, S | 1 |
Pathania, S; Rawal, RK; Singh, PK | 1 |
Chou, JT; Hana, D; Kaczmarek, M; Khalaf, K; Mackiewicz, A; Papp, N | 1 |
Farley, TM; Sabers, AJ; Williams, AL | 1 |
Alabed, SJ; Dahabiyeh, LA; Daoud, S | 1 |
Niburski, K; Niburski, O | 1 |
Arbustini, E; Bergomi, P; Bozzini, S; Cavagna, L; Colombo, R; Corsico, AG; Cova, E; D'Amato, M; Di Toro, A; Fossali, T; Frangipane, V; Lettieri, S; Lilleri, D; Meloni, F; Mojoli, F; Morosini, M; Ottolina, D; Pandolfi, L; Percivalle, E; Saracino, L; Tomaselli, S; Urtis, M | 1 |
Chen, CH; Liu, HY; Pan, MY | 1 |
Cheung, WL; Cowart, MC; Gomez, MR; Gutierrez, LD; Hopwood, AJ; Jordan-Villegas, A; Laham, FR; McMahan, MJ; Vega-Montalvo, W | 1 |
Trkulja, V | 1 |
Abraham, GM; Andrews, R; Centor, RM; Etxeandia-Ikobaltzeta, I; Forciea, MA; Haeme, R; Humphrey, LL; Jokela, JA; Miller, MC; Qaseem, A; Yost, J | 1 |
Duan-Porter, W; Greer, N; Kaka, AS; MacDonald, R; Obley, A; Vela, K; Wilt, TJ | 1 |
Bhagavan, SM; Govindarajan, R; Ramaswamy, SB | 1 |
Cipriani, L; Forner, G; Furlan, A; Gherlinzoni, F; Rigoli, R; Scotton, P; Vian, E | 1 |
85 review(s) available for adenosine monophosphate and Pneumonia, Viral
Article | Year |
---|---|
Understanding of COVID-19 based on current evidence.
Topics: Adenosine Monophosphate; Adrenal Cortex Hormones; Alanine; Animals; Antiviral Agents; Betacoronavirus; China; Chiroptera; Communicable Disease Control; Coronavirus Infections; COVID-19; Disease Management; Humans; Oseltamivir; Pandemics; Pneumonia, Viral; SARS-CoV-2; Survival Analysis | 2020 |
Clinical trial analysis of 2019-nCoV therapy registered in China.
Topics: Adenosine Monophosphate; Alanine; Amides; Antiviral Agents; Betacoronavirus; China; Chloroquine; Clinical Trials as Topic; Coronavirus Infections; COVID-19; Disease Management; Disease Outbreaks; Drugs, Chinese Herbal; Humans; Medicine, Chinese Traditional; Pandemics; Pneumonia, Viral; Practice Guidelines as Topic; Pyrazines; SARS-CoV-2 | 2020 |
Compounds with Therapeutic Potential against Novel Respiratory 2019 Coronavirus.
Topics: Adenosine Monophosphate; Alanine; Animals; Antibodies, Monoclonal; Antiviral Agents; Betacoronavirus; Clinical Trials as Topic; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; COVID-19 Serotherapy; Drug Combinations; Humans; Immunization, Passive; Interferon-beta; Lopinavir; Mice, Transgenic; Middle East Respiratory Syndrome Coronavirus; Pandemics; Pneumonia, Viral; Ribavirin; Ritonavir; SARS-CoV-2; Severe acute respiratory syndrome-related coronavirus; Spike Glycoprotein, Coronavirus | 2020 |
[Pharmacotherapeutics for the new coronavirus pneumonia].
Topics: Adenosine; Adenosine Monophosphate; Alanine; Anti-Bacterial Agents; Antiviral Agents; China; Coronavirus Infections; COVID-19; Cytochrome P-450 CYP3A Inhibitors; Drug Therapy, Combination; Humans; Lopinavir; Pneumonia, Viral; Retrospective Studies; Ribonucleotides; Ritonavir | 2020 |
Asymptomatic carrier state, acute respiratory disease, and pneumonia due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): Facts and myths.
Topics: Adenosine Monophosphate; Adolescent; Adult; Aged; Alanine; Asymptomatic Infections; Betacoronavirus; China; Chloroquine; Comorbidity; Coronavirus Infections; COVID-19; Humans; Infection Control; Middle Aged; Pandemics; Pneumonia, Viral; SARS-CoV-2; Young Adult | 2020 |
[Remdesivir, the antiviral hope against SARS-CoV-2].
Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; Humans; Pandemics; Pneumonia, Viral; SARS-CoV-2 | 2020 |
Potential therapeutic agents against COVID-19: What we know so far.
Topics: Adenosine Monophosphate; Alanine; Betacoronavirus; Clinical Trials as Topic; Coronavirus Infections; COVID-19; Drug Combinations; Humans; Hydroxychloroquine; Interferon-alpha; Lopinavir; Pandemics; Pneumonia, Viral; Ritonavir; SARS-CoV-2 | 2020 |
Review of Emerging Pharmacotherapy for the Treatment of Coronavirus Disease 2019.
Topics: Adenosine Monophosphate; Adrenal Cortex Hormones; Alanine; Antibodies, Monoclonal, Humanized; Antiviral Agents; Azetidines; Betacoronavirus; Chloroquine; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; COVID-19 Serotherapy; Drug Combinations; Humans; Hydroxychloroquine; Immunization, Passive; Immunomodulation; Interferon-alpha; Lopinavir; Nelfinavir; Nitro Compounds; Pandemics; Pneumonia, Viral; Purines; Pyrazoles; Ribavirin; Ritonavir; SARS-CoV-2; Sulfonamides; Thiazoles | 2020 |
Drug repositioning is an alternative for the treatment of coronavirus COVID-19.
Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Betacoronavirus; Chloroquine; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Drug Repositioning; Humans; Hydroxychloroquine; Pandemics; Pneumonia, Viral; SARS-CoV-2; Teicoplanin | 2020 |
Pharmacologic Treatments for Coronavirus Disease 2019 (COVID-19): A Review.
Topics: Adenosine Monophosphate; Adrenal Cortex Hormones; Alanine; Amides; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antiviral Agents; Azithromycin; Betacoronavirus; Chloroquine; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Humans; Hydroxychloroquine; Immunoglobulins; Immunologic Factors; Indoles; Lopinavir; Oseltamivir; Pandemics; Pneumonia, Viral; Pyrazines; Ribavirin; Ritonavir; SARS-CoV-2; Withholding Treatment | 2020 |
Antiviral treatment of COVID-19
Topics: Adenosine Monophosphate; Alanine; Amides; Antiviral Agents; Betacoronavirus; Chloroquine; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Drug Combinations; Humans; Hydroxychloroquine; Ivermectin; Lopinavir; Nitro Compounds; Pandemics; Pneumonia, Viral; Pyrazines; Ritonavir; SARS-CoV-2; Thiazoles | 2020 |
Pharmacologic Treatment of Transplant Recipients Infected With SARS-CoV-2: Considerations Regarding Therapeutic Drug Monitoring and Drug-Drug Interactions.
Topics: Adenosine Monophosphate; Alanine; Antibodies, Monoclonal, Humanized; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; Drug Interactions; Drug Monitoring; Glucocorticoids; Humans; Hydroxychloroquine; Immunosuppressive Agents; Pandemics; Pneumonia, Viral; Protease Inhibitors; SARS-CoV-2; Transplant Recipients | 2020 |
Novel 2019 coronavirus: Genome structure, clinical trials, and outstanding questions.
Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Betacoronavirus; China; Communicable Disease Control; Coronavirus Infections; COVID-19; Genome, Viral; Humans; Middle East Respiratory Syndrome Coronavirus; Pandemics; Pneumonia, Viral; SARS-CoV-2; Serine Proteinase Inhibitors; Severe acute respiratory syndrome-related coronavirus | 2020 |
Treatment options for COVID-19: The reality and challenges.
Topics: Adenosine Monophosphate; Alanine; Amides; Antiviral Agents; Azithromycin; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Serotherapy; Drug Combinations; Humans; Hydroxychloroquine; Immunization, Passive; Lopinavir; Pandemics; Pneumonia, Viral; Pyrazines; Ritonavir; RNA-Dependent RNA Polymerase; SARS-CoV-2; Teicoplanin | 2020 |
Respiratory Support in COVID-19 Patients, with a Focus on Resource-Limited Settings.
Topics: Adenosine Monophosphate; Alanine; Betacoronavirus; Chloroquine; Continuous Positive Airway Pressure; Coronavirus Infections; COVID-19; Developing Countries; Disease Management; Humans; Hydroxychloroquine; Lopinavir; Lung; Oxygen; Pandemics; Pneumonia, Viral; Respiration, Artificial; Ritonavir; SARS-CoV-2; Tomography, X-Ray Computed | 2020 |
Scientific research progress of COVID-19/SARS-CoV-2 in the first five months.
Topics: Adenosine Monophosphate; Alanine; Amides; Angiotensin-Converting Enzyme 2; Angiotensin-Converting Enzyme Inhibitors; Antiviral Agents; Betacoronavirus; Clinical Laboratory Techniques; Coronavirus Infections; COVID-19; COVID-19 Serotherapy; COVID-19 Testing; COVID-19 Vaccines; Disease Progression; Gene Expression Regulation; Host-Pathogen Interactions; Humans; Immunization, Passive; Pandemics; Peptidyl-Dipeptidase A; Pneumonia, Viral; Pyrazines; SARS-CoV-2; Severity of Illness Index; Spike Glycoprotein, Coronavirus; Viral Vaccines | 2020 |
[Remdesivir for patients with severe COVID-19].
Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Coronavirus Infections; COVID-19; Humans; Pandemics; Pneumonia, Viral; Severity of Illness Index | 2020 |
Pharmacotherapy in COVID-19; A narrative review for emergency providers.
Topics: Adenosine Monophosphate; Adrenal Cortex Hormones; Alanine; Amides; Angiotensin-Converting Enzyme Inhibitors; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; Drug Therapy, Combination; Emergency Service, Hospital; Humans; Hydroxychloroquine; Interleukin-6; Pandemics; Pneumonia, Viral; Pyrazines; Randomized Controlled Trials as Topic; SARS-CoV-2 | 2020 |
Treatment of SARS-CoV-2: How far have we reached?
Topics: Adenosine Monophosphate; Alanine; Amides; Antibodies, Monoclonal, Humanized; Antiviral Agents; Betacoronavirus; Chloroquine; Clinical Trials as Topic; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; COVID-19 Serotherapy; Darunavir; Drug Combinations; Humans; Hydroxychloroquine; Immunization, Passive; Indoles; Interferon-alpha; Interferon-beta; Lopinavir; Pandemics; Pneumonia, Viral; Pyrazines; Ritonavir; SARS-CoV-2 | 2020 |
Addressing the Impact of the Coronavirus Disease 2019 (COVID-19) Pandemic on Hematopoietic Cell Transplantation: Learning Networks as a Means for Sharing Best Practices.
Topics: Adenosine Monophosphate; Alanine; Betacoronavirus; Bone Marrow Transplantation; Clinical Laboratory Techniques; Coronavirus Infections; COVID-19; COVID-19 Serotherapy; COVID-19 Testing; Drug Combinations; Education, Distance; Hematopoietic Stem Cell Transplantation; Humans; Hydroxychloroquine; Immunization, Passive; Infection Control; Information Dissemination; Lopinavir; Pandemics; Pneumonia, Viral; Practice Guidelines as Topic; Real-Time Polymerase Chain Reaction; Ritonavir; SARS-CoV-2; Severity of Illness Index; Tissue Donors | 2020 |
Medical treatment options for COVID-19.
Topics: Adenosine Monophosphate; Administration, Intravenous; Alanine; Amides; Antibodies, Monoclonal, Humanized; Antiviral Agents; Betacoronavirus; Chloroquine; Clinical Trials as Topic; Coronavirus Infections; COVID-19; Cytochrome P-450 CYP3A Inhibitors; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Immunologic Factors; Lopinavir; Pandemics; Pneumonia, Viral; Pyrazines; Recombinant Proteins; RNA, Viral; SARS-CoV-2 | 2020 |
Potential therapeutic targets and promising drugs for combating SARS-CoV-2.
Topics: Adenosine Monophosphate; Alanine; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme 2; Angiotensin-Converting Enzyme Inhibitors; Antiviral Agents; Basigin; Benzamidines; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; COVID-19 Serotherapy; COVID-19 Vaccines; Cytokine Release Syndrome; Esters; Gabexate; Genome, Viral; Guanidines; Humans; Immunization, Passive; Immunosuppressive Agents; Medicine, Chinese Traditional; Nucleic Acid Synthesis Inhibitors; Pandemics; Peptidyl-Dipeptidase A; Pneumonia, Viral; Protease Inhibitors; RNA-Dependent RNA Polymerase; SARS-CoV-2; Serine Endopeptidases; Spike Glycoprotein, Coronavirus; Viral Vaccines; Virus Internalization; Virus Replication | 2020 |
Rapid review for the anti-coronavirus effect of remdesivir.
Topics: Adenosine Monophosphate; Alanine; Animals; Antiviral Agents; Betacoronavirus; Clinical Trials as Topic; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Drug Evaluation, Preclinical; Humans; Middle East Respiratory Syndrome Coronavirus; Pandemics; Pneumonia, Viral; SARS-CoV-2; Severe acute respiratory syndrome-related coronavirus | 2020 |
COVID-19: Pathogenesis, cytokine storm and therapeutic potential of interferons.
Topics: Adenosine Monophosphate; Alanine; Antibodies, Monoclonal; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; Cytokine Release Syndrome; Cytokines; Drug Therapy, Combination; Humans; Inflammation; Interferons; Oligonucleotides; Pandemics; Pneumonia, Viral; SARS-CoV-2; Viral Vaccines | 2020 |
Medicines for the Treatment Of COVID-19: Awaiting the Evidence.
Topics: Adenosine Monophosphate; Alanine; Antibodies, Monoclonal, Humanized; Antiviral Agents; Betacoronavirus; Chloroquine; Coronavirus Infections; COVID-19; Drug Combinations; Drugs, Investigational; Global Health; Humans; Hydroxychloroquine; Lopinavir; Off-Label Use; Pandemics; Pneumonia, Viral; Ritonavir; SARS-CoV-2 | 2020 |
Cardiovascular Safety of Potential Drugs for the Treatment of Coronavirus Disease 2019.
Topics: Adenosine Monophosphate; Alanine; Anti-Infective Agents; Azithromycin; Betacoronavirus; Cardiovascular Diseases; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Drug Combinations; Enzyme Inhibitors; Humans; Hydroxychloroquine; Lopinavir; Pandemics; Pneumonia, Viral; Ritonavir; SARS-CoV-2 | 2020 |
Just the facts: What drugs are safe and effective for COVID-19?
Topics: Adenosine Monophosphate; Alanine; Angiotensin-Converting Enzyme Inhibitors; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Antimalarials; Antiviral Agents; Coronavirus Infections; COVID-19; Drug Therapy; Humans; Male; Middle Aged; Needs Assessment; Pandemics; Patient Safety; Pneumonia, Viral; Risk Assessment; Severe Acute Respiratory Syndrome; Severity of Illness Index; Steroids; Treatment Outcome | 2020 |
Remdesivir: Review of Pharmacology, Pre-clinical Data, and Emerging Clinical Experience for COVID-19.
Topics: Adenosine Monophosphate; Alanine; Animals; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Humans; Pandemics; Pneumonia, Viral; SARS-CoV-2 | 2020 |
Remdesivir in Treatment of COVID-19: A Systematic Benefit-Risk Assessment.
Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; Humans; Pandemics; Pneumonia, Viral; Risk Assessment; SARS-CoV-2; Treatment Outcome | 2020 |
Educational case series of electrocardiographs during the COVID-19 pandemic and the implications for therapy.
Topics: Adenosine Monophosphate; Adult; Aged; Alanine; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Coronavirus Infections; COVID-19; Echocardiography; Electrocardiography; Female; Follow-Up Studies; Humans; Male; Pandemics; Pneumonia, Viral; Sampling Studies; Severe Acute Respiratory Syndrome; Singapore; Treatment Outcome | 2020 |
A current review of COVID-19 for the cardiovascular specialist.
Topics: Adenosine Monophosphate; Alanine; Antimalarials; Antiviral Agents; Betacoronavirus; Biomarkers; Cardiovascular Diseases; Chloroquine; Coronavirus Infections; COVID-19; Humans; Hydroxychloroquine; Hypoxia; Pandemics; Plasma; Pneumonia, Viral; Receptor, Angiotensin, Type 2; Risk Factors; SARS-CoV-2; Takotsubo Cardiomyopathy; Virus Internalization | 2020 |
Coronavirus Disease 2019: Clinical Review.
Topics: Adenosine Monophosphate; Alanine; Amides; Animals; Antiviral Agents; Azithromycin; Betacoronavirus; Blood Coagulation Disorders; China; Chiroptera; Chloroquine; Coronavirus Infections; COVID-19; Glucocorticoids; Humans; Hydroxychloroquine; Infectious Disease Incubation Period; Lopinavir; Lung; Pandemics; Pneumonia, Viral; Prognosis; Pyrazines; Radiography, Thoracic; Reverse Transcriptase Polymerase Chain Reaction; SARS-CoV-2; Symptom Assessment | 2020 |
COVID-19: The Potential Role of Copper and N-acetylcysteine (NAC) in a Combination of Candidate Antiviral Treatments Against SARS-CoV-2.
Topics: Acetylcysteine; Adenosine Monophosphate; Adjuvants, Immunologic; Alanine; Anti-Inflammatory Agents; Antiviral Agents; Autophagy; Betacoronavirus; Colchicine; Copper; Coronavirus Infections; COVID-19; Cytidine; Drug Synergism; Drug Therapy, Combination; Humans; Hydroxylamines; Inflammation; Nitric Oxide; Pandemics; Pneumonia, Viral; Prodrugs; Ribonucleosides; SARS-CoV-2; Virus Internalization; Virus Replication | 2020 |
Potential Antiviral Drugs for SARS-Cov-2 Treatment: Preclinical Findings and Ongoing Clinical Research.
Topics: Adenosine Monophosphate; Alanine; Animals; Antibodies, Monoclonal, Humanized; Antiviral Agents; Betacoronavirus; Chloroquine; Clinical Trials as Topic; Coronavirus Infections; COVID-19; Drug Combinations; Drug Evaluation, Preclinical; Drug Synergism; Drug Therapy, Combination; Drugs, Investigational; Humans; Indoles; Lopinavir; Multicenter Studies as Topic; Neuraminidase; Pandemics; Pneumonia, Viral; Primates; Ribavirin; Ritonavir; SARS-CoV-2; Treatment Outcome | 2020 |
Use of Remdesivir in the Management of COVID-19: A Systematic Review on Current Evidences.
Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Humans; Pandemics; Pneumonia, Viral; Prospective Studies; Randomized Controlled Trials as Topic; SARS-CoV-2 | 2020 |
Remdesivir in Patients with Acute or Chronic Kidney Disease and COVID-19.
Topics: Acute Kidney Injury; Adenosine Monophosphate; Alanine; Antiviral Agents; Cause of Death; Comorbidity; Coronavirus Infections; COVID-19; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Injections, Intravenous; Kidney Failure, Chronic; Male; Massachusetts; Pandemics; Pneumonia, Viral; Prognosis; Randomized Controlled Trials as Topic; Risk Assessment; Survival Rate | 2020 |
Potential drugs for the treatment of the novel coronavirus pneumonia (COVID-19) in China.
Topics: Adenosine Monophosphate; Alanine; Amides; Antiviral Agents; Betacoronavirus; China; Chloroquine; Coronavirus Infections; COVID-19; Drug Combinations; Drugs, Chinese Herbal; Humans; Indoles; Interferons; Lopinavir; Lung; Pandemics; Pneumonia, Viral; Pyrazines; Ribavirin; Ritonavir; SARS-CoV-2; Survival Analysis | 2020 |
Infant With SARS-CoV-2 Infection Causing Severe Lung Disease Treated With Remdesivir.
Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Female; Humans; Infant; Infant, Premature; Intensive Care Units; Intubation, Intratracheal; Pandemics; Patient Discharge; Pneumonia, Viral; Radiography, Thoracic; Respiration, Artificial; Severe Acute Respiratory Syndrome; Treatment Outcome | 2020 |
[COVID-19 trials: surfing between expectations and illusions, looking forward to evidence].
Topics: Adenosine Monophosphate; Alanine; Coronavirus Infections; COVID-19; Female; Humans; Hydroxychloroquine; Italy; Male; Pandemics; Pneumonia, Viral; Prevalence; Randomized Controlled Trials as Topic; Risk Assessment | 2020 |
Investigational Therapies for the Treatment of COVID-19: Updates from Ongoing Clinical Trials.
Topics: Adenosine Monophosphate; Alanine; Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Antiviral Agents; Betacoronavirus; Chloroquine; Clinical Trials as Topic; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; COVID-19 Serotherapy; Humans; Hydroxychloroquine; Immunization, Passive; Immunologic Factors; Pandemics; Pneumonia, Viral; Receptors, Interleukin-6; SARS-CoV-2 | 2020 |
A promising antiviral candidate drug for the COVID-19 pandemic: A mini-review of remdesivir.
Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Betacoronavirus; Clinical Trials as Topic; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Humans; Pandemics; Pneumonia, Viral; SARS-CoV-2 | 2020 |
Emerging pharmacotherapy for COVID-19.
Topics: Adenosine Monophosphate; Alanine; Anti-Inflammatory Agents; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; Cytokines; Enzyme Inhibitors; Humans; Hydroxychloroquine; Pandemics; Pneumonia, Viral; SARS-CoV-2 | 2020 |
Have we found the panacea to COVID-19 with remdesivir, an old but newly packaged drug?
Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Betacoronavirus; Compassionate Use Trials; Coronavirus Infections; COVID-19; Humans; Pandemics; Pneumonia, Viral; SARS-CoV-2; Treatment Outcome | 2020 |
COVID-19: Review on latest available drugs and therapies against SARS-CoV-2. Coagulation and inflammation cross-talking.
Topics: Adenosine Monophosphate; Alanine; Anti-Inflammatory Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Neutralizing; Anticoagulants; Antiviral Agents; Azetidines; Betacoronavirus; Coronavirus Infections; COVID-19; Cytokine Release Syndrome; Disseminated Intravascular Coagulation; Drug Combinations; Heparin; Humans; Hydroxychloroquine; Inflammation; Interleukin 1 Receptor Antagonist Protein; Lopinavir; Pandemics; Pneumonia, Viral; Purines; Pyrazoles; Ritonavir; SARS-CoV-2; Sulfonamides | 2020 |
[Drug treatment of coronavirus disease COVID-19: evidence exists?]
Topics: Adenosine Monophosphate; Alanine; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Betacoronavirus; Chloroquine; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; COVID-19 Serotherapy; Drug Combinations; Humans; Hydroxychloroquine; Immunization, Passive; Lopinavir; Pandemics; Pneumonia, Viral; Ritonavir; SARS-CoV-2; Tissue Plasminogen Activator | 2020 |
Antiviral mechanisms of candidate chemical medicines and traditional Chinese medicines for SARS-CoV-2 infection.
Topics: Adenosine Monophosphate; Alanine; Amides; Antiviral Agents; Betacoronavirus; China; Coronavirus Infections; COVID-19; Drug Combinations; Drugs, Chinese Herbal; Humans; Hydroxychloroquine; Indoles; Interferons; Lopinavir; Pandemics; Pneumonia, Viral; Pyrazines; Ribavirin; Ritonavir; SARS-CoV-2; Survival Analysis; Teicoplanin | 2020 |
Current pharmacological treatments for SARS-COV-2: A narrative review.
Topics: Adenosine Monophosphate; Adjuvants, Immunologic; Alanine; Antiviral Agents; Betacoronavirus; Clinical Trials as Topic; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Glucocorticoids; Heparin, Low-Molecular-Weight; Humans; Hydroxychloroquine; Immunity, Innate; Inflammation Mediators; Oseltamivir; Pandemics; Pneumonia, Viral; SARS-CoV-2; Treatment Outcome | 2020 |
Clinical management of COVID-19.
Topics: Adenosine Monophosphate; Adrenal Cortex Hormones; Airway Management; Alanine; Antibodies, Monoclonal, Humanized; Antimalarials; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Serotherapy; Critical Illness; Humans; Hydroxychloroquine; Immunization, Passive; Pandemics; Patient Acuity; Pneumonia, Viral; SARS-CoV-2; Shock; Specimen Handling; Symptom Assessment; Vulnerable Populations | 2020 |
Molecular mechanisms and epidemiology of COVID-19 from an allergist's perspective.
Topics: Adenosine Monophosphate; Age Factors; Alanine; Angiotensin-Converting Enzyme 2; Antiviral Agents; Asthma; Betacoronavirus; Clinical Laboratory Techniques; Clinical Trials as Topic; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; COVID-19 Testing; Drug Repositioning; Humans; Masks; Pandemics; Peptidyl-Dipeptidase A; Physical Distancing; Pneumonia, Viral; Prevalence; Quarantine; Receptors, Virus; SARS-CoV-2; Severity of Illness Index; Spike Glycoprotein, Coronavirus | 2020 |
Clinical Trials of Repurposed Antivirals for SARS-CoV-2.
Topics: Adenosine Monophosphate; Alanine; Amides; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; Drug Administration Schedule; Drug Combinations; Drug Repositioning; Humans; Hydroxychloroquine; Interferons; Lopinavir; Pandemics; Pneumonia, Viral; Pyrazines; Randomized Controlled Trials as Topic; Ribavirin; Ritonavir; SARS-CoV-2; Survival Analysis; Treatment Outcome | 2020 |
CNS Penetration Ability: A Critical Factor for Drugs in the Treatment of SARS-CoV-2 Brain Infection.
Topics: Adenosine Monophosphate; Alanine; Animals; Anti-Inflammatory Agents; Antiviral Agents; Betacoronavirus; Blood-Brain Barrier; Brain; Central Nervous System Agents; Coronavirus Infections; COVID-19; Drug Evaluation, Preclinical; Humans; Methylprednisolone; Pandemics; Pneumonia, Viral; SARS-CoV-2; Treatment Outcome | 2020 |
Is hydroxychloroquine beneficial for COVID-19 patients?
Topics: Adenosine Monophosphate; Alanine; Anti-Inflammatory Agents; Antiviral Agents; Betacoronavirus; Chloroquine; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Cytokines; Humans; Hydroxychloroquine; Pandemics; Pneumonia, Viral; Risk; SARS-CoV-2 | 2020 |
Current pharmacological modalities for management of novel coronavirus disease 2019 (COVID-19) and the rationale for their utilization: A review.
Topics: Adenosine Monophosphate; Alanine; Angiotensin-Converting Enzyme 2; Antibodies, Monoclonal, Humanized; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; Disease Progression; Drug Combinations; Drug Repositioning; Esters; Gabexate; Gene Expression Regulation; Guanidines; Host-Pathogen Interactions; Humans; Hydroxychloroquine; Indoles; Lopinavir; Pandemics; Peptidyl-Dipeptidase A; Pneumonia, Viral; Ritonavir; SARS-CoV-2; Spike Glycoprotein, Coronavirus | 2020 |
Characteristics of the Multiplicity of Randomized Clinical Trials for Coronavirus Disease 2019 Launched During the Pandemic.
Topics: Adenosine Monophosphate; Alanine; Anti-Bacterial Agents; Antibodies, Monoclonal, Humanized; Antimalarials; Antiviral Agents; Azithromycin; Betacoronavirus; Biological Products; Chloroquine; Coronavirus Infections; COVID-19; COVID-19 Serotherapy; Humans; Hydroxychloroquine; Immunization, Passive; Non-Randomized Controlled Trials as Topic; Pandemics; Pneumonia, Viral; Protease Inhibitors; Protein-Tyrosine Kinases; Randomized Controlled Trials as Topic; Respiration, Artificial; SARS-CoV-2; Viral Load | 2020 |
Re-tasking the use of pre-existing medications and potential therapeutic options for coronavirus disease (COVID-19): systematic review of clinical studies.
Topics: Adenosine Monophosphate; Alanine; Antirheumatic Agents; Antiviral Agents; Betacoronavirus; Clinical Trials as Topic; Coronavirus Infections; COVID-19; Drug Repositioning; Humans; Hydroxychloroquine; Pandemics; Pneumonia, Viral; SARS-CoV-2 | 2020 |
An overview of the safety, clinical application and antiviral research of the COVID-19 therapeutics.
Topics: Adenosine Monophosphate; Alanine; Amides; Angiotensin-Converting Enzyme Inhibitors; Antimalarials; Antiviral Agents; Betacoronavirus; Biomedical Research; Coronavirus Infections; COVID-19; COVID-19 Serotherapy; Drug Combinations; Drug Development; Drugs, Chinese Herbal; Humans; Hydroxychloroquine; Immunization, Passive; Indoles; Interferons; Lopinavir; Pandemics; Pneumonia, Viral; Pyrazines; Ribavirin; Ritonavir; SARS-CoV-2 | 2020 |
Use of remdesivir for patients with Covid-19: a review article.
Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Humans; Pandemics; Pneumonia, Viral; SARS-CoV-2 | 2020 |
Emerging treatments in COVID-19: Adverse drug reactions including drug hypersensitivities.
Topics: Adenosine Monophosphate; Adrenal Cortex Hormones; Alanine; Amides; Antibodies, Monoclonal, Humanized; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; Cytokine Release Syndrome; Drug Hypersensitivity; Humans; Immunity, Innate; Immunologic Factors; Indoles; Infliximab; Interleukin 1 Receptor Antagonist Protein; Nitriles; Pandemics; Pneumonia, Viral; Pyrazines; Pyrazoles; Pyrimidines; SARS-CoV-2; Severity of Illness Index | 2020 |
Nanomedicine as a promising approach for diagnosis, treatment and prophylaxis against COVID-19.
Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Betacoronavirus; Clinical Laboratory Techniques; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; COVID-19 Testing; COVID-19 Vaccines; Drug Repositioning; Host Microbial Interactions; Humans; Nanomedicine; Nanotechnology; Pandemics; Pneumonia, Viral; SARS-CoV-2; Vaccines, Synthetic; Viral Vaccines | 2020 |
Remdesivir for the Treatment of COVID-19: A Systematic Review of the Literature.
Topics: Adenosine Monophosphate; Administration, Intravenous; Alanine; Antiviral Agents; Betacoronavirus; Clinical Trials as Topic; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Humans; Pandemics; Pneumonia, Viral; SARS-CoV-2; Treatment Outcome | 2020 |
COVID-19 and liver disease: An update.
Topics: Adenosine Monophosphate; Age Factors; Alanine; Antiviral Agents; Betacoronavirus; Bile Ducts; Chemical and Drug Induced Liver Injury; Chronic Disease; Comorbidity; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Disease Susceptibility; Gastroenterology; Health Resources; Hepatitis, Chronic; Humans; Immunosuppressive Agents; Liver; Liver Diseases; Liver Function Tests; Liver Transplantation; Obesity; Pandemics; Pneumonia, Viral; Resource Allocation; Risk Factors; SARS-CoV-2 | 2020 |
Drug treatments for covid-19: living systematic review and network meta-analysis
Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Betacoronavirus; Centers for Disease Control and Prevention, U.S.; China; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Databases, Factual; Drug Combinations; Evidence-Based Medicine; Glucocorticoids; Humans; Hydroxychloroquine; Lopinavir; Network Meta-Analysis; Pandemics; Pneumonia, Viral; Randomized Controlled Trials as Topic; Respiration, Artificial; Ritonavir; SARS-CoV-2; Severity of Illness Index; Standard of Care; Treatment Outcome; United States | 2020 |
Update on recommendations for the diagnosis and treatment of SARS-CoV-2 infection in children.
Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Asymptomatic Diseases; Betacoronavirus; Biomarkers; Child; Clinical Laboratory Techniques; Coronavirus Infections; Cough; COVID-19; COVID-19 Testing; Drug Combinations; Early Diagnosis; Fever; Humans; Hydroxychloroquine; Interferon-alpha; Lopinavir; Pandemics; Pneumonia, Viral; Practice Guidelines as Topic; Ribavirin; Ritonavir; RNA, Viral; SARS-CoV-2; Severity of Illness Index; Tomography, X-Ray Computed | 2020 |
Clinical efficacy of antivirals against novel coronavirus (COVID-19): A review.
Topics: Adenosine Monophosphate; Alanine; Amides; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; Drug Combinations; Humans; Indoles; Lopinavir; Pandemics; Pneumonia, Viral; Pyrazines; Ritonavir; SARS-CoV-2 | 2020 |
Potential strategies for combating COVID-19.
Topics: Adenosine Monophosphate; Adrenal Cortex Hormones; Alanine; Amides; Antibodies, Monoclonal, Humanized; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Serotherapy; COVID-19 Vaccines; Cytokine Release Syndrome; Drug Combinations; Humans; Hydroxychloroquine; Immunization, Passive; Immunologic Factors; Indoles; Interleukin 1 Receptor Antagonist Protein; Lopinavir; Pandemics; Pneumonia, Viral; Pyrazines; Ritonavir; SARS-CoV-2; Severity of Illness Index; Viral Vaccines | 2020 |
Efficacy of various treatment modalities for nCOV-2019: A systematic review and meta-analysis.
Topics: Adenosine Monophosphate; Alanine; Antibodies, Monoclonal, Humanized; Antiviral Agents; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Europe; Female; Humans; Lopinavir; Male; Pandemics; Pneumonia, Viral; Prognosis; Ritonavir; Survival Analysis; Treatment Outcome | 2020 |
A Review on Remdesivir: A Possible Promising Agent for the Treatment of COVID-19.
Topics: Adenosine Monophosphate; Alanine; Animals; Antiviral Agents; Clinical Trials as Topic; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Humans; Pandemics; Pneumonia, Viral; Virus Replication | 2020 |
Effect of remdesivir on patients with COVID-19: A network meta-analysis of randomized control trials.
Topics: Adenosine Monophosphate; Alanine; Antimetabolites; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; Disease Progression; Drug Administration Schedule; Humans; Pandemics; Pneumonia, Viral; Randomized Controlled Trials as Topic; SARS-CoV-2; Severity of Illness Index; Survival Analysis; Treatment Outcome | 2020 |
Understanding the epidemiology, pathophysiology, diagnosis and management of SARS-CoV-2.
Topics: Adenosine Monophosphate; Age Factors; Alanine; Antibodies, Monoclonal, Humanized; Antiviral Agents; Betacoronavirus; Chloroquine; Communicable Disease Control; Coronavirus Infections; COVID-19; Drug Repositioning; Humans; Incidence; Pandemics; Personal Protective Equipment; Physical Distancing; Pneumonia, Viral; Quarantine; SARS-CoV-2; Severity of Illness Index; Survival Analysis | 2020 |
Coronavirus RNA Proofreading: Molecular Basis and Therapeutic Targeting.
Topics: Adenosine Monophosphate; Alanine; Amides; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; Cytidine; Genome, Viral; Humans; Hydroxylamines; Molecular Targeted Therapy; Mutation; Pandemics; Pneumonia, Viral; Pyrazines; Ribonucleosides; RNA, Viral; SARS-CoV-2; Severity of Illness Index; Transcription, Genetic; Viral Nonstructural Proteins; Virus Replication | 2020 |
Developing an Ethics Framework for Allocating Remdesivir in the COVID-19 Pandemic.
Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; Drugs, Investigational; Health Care Rationing; Humans; Minnesota; Pandemics; Pneumonia, Viral; SARS-CoV-2; United States; United States Food and Drug Administration | 2020 |
Insights into antiviral mechanisms of remdesivir, lopinavir/ritonavir and chloroquine/hydroxychloroquine affecting the new SARS-CoV-2.
Topics: Adenosine Monophosphate; Alanine; Animals; Antiviral Agents; Betacoronavirus; Chloroquine; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Drug Combinations; Humans; Hydroxychloroquine; Lopinavir; Pandemics; Pneumonia, Viral; Ritonavir; SARS-CoV-2 | 2020 |
Remdesivir: First Approval.
Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; Drug Development; Humans; Pandemics; Pneumonia, Viral; SARS-CoV-2 | 2020 |
Remdesivir emergency approvals: a comparison of the U.S., Japanese, and EU systems.
Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Betacoronavirus; Compassionate Use Trials; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Drug Approval; Emergency Medical Services; European Union; Humans; Japan; Pandemics; Pneumonia, Viral; SARS-CoV-2; United States | 2020 |
Progress in Studies on Structural and Remedial Aspects of Newly Born Coronavirus, SARS-CoV-2.
Topics: Adenosine Monophosphate; Alanine; Angiotensin-Converting Enzyme 2; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Serotherapy; COVID-19 Vaccines; Gene Expression; Host-Pathogen Interactions; Humans; Hydroxychloroquine; Immunization, Passive; Ivermectin; Models, Molecular; Niclosamide; Pandemics; Peptidyl-Dipeptidase A; Pneumonia, Viral; Protein Interaction Domains and Motifs; Protein Structure, Secondary; SARS-CoV-2; Severe Acute Respiratory Syndrome; Severe acute respiratory syndrome-related coronavirus; Spike Glycoprotein, Coronavirus; Viral Vaccines | 2020 |
A contemporary look at COVID-19 medications: available and potentially effective drugs.
Topics: Adenosine Monophosphate; Alanine; Anti-Inflammatory Agents, Non-Steroidal; Antiviral Agents; Betacoronavirus; Chloroquine; Coronavirus Infections; COVID-19; Humans; Imatinib Mesylate; Lopinavir; Pandemics; Pneumonia, Viral; Ritonavir; SARS-CoV-2 | 2020 |
Advances in SARS-CoV-2: a systematic review.
Topics: Adenosine Monophosphate; Alanine; Angiotensin-Converting Enzyme 2; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; Extracorporeal Membrane Oxygenation; Glucocorticoids; Humans; Immunization, Passive; Immunotherapy; Pandemics; Peptidyl-Dipeptidase A; Pneumonia, Viral; SARS-CoV-2 | 2020 |
Current treatment of COVID-19 in renal patients: hope or hype?
Topics: Adenosine Monophosphate; Adrenal Cortex Hormones; Alanine; Amides; Antibodies, Monoclonal; Cobicistat; Coronavirus Infections; COVID-19; Darunavir; Drug Combinations; Humans; Kidney; Lopinavir; Pandemics; Pneumonia, Viral; Pyrazines; Renal Insufficiency, Chronic; Renal Replacement Therapy; Ritonavir | 2020 |
Remdesivir-COVID-19: drug interactions in dentistry.
Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; Dentistry; Drug Interactions; Humans; Pandemics; Pneumonia, Viral; SARS-CoV-2 | 2020 |
Systemic Medications of Dermatological Importance in COVID-19.
Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Biological Products; Coronavirus Infections; COVID-19; Dermatologic Agents; Drug Eruptions; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Incidence; Male; Pandemics; Pneumonia, Viral; Prognosis; Risk Assessment; Severe Acute Respiratory Syndrome | 2020 |
Remdesivir against COVID-19 and Other Viral Diseases.
Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Betacoronavirus; Clinical Trials as Topic; Compassionate Use Trials; Coronavirus Infections; COVID-19; Drug Administration Schedule; Ebolavirus; Hemorrhagic Fever, Ebola; Humans; Middle East Respiratory Syndrome Coronavirus; Pandemics; Patient Safety; Pneumonia, Viral; SARS-CoV-2; Severe Acute Respiratory Syndrome; Severe acute respiratory syndrome-related coronavirus; Survival Analysis; Treatment Outcome | 2020 |
Severe Acute Respiratory Distress Syndrome Secondary to Coronavirus 2 (SARS-CoV-2).
Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Serotherapy; Humans; Immunization, Passive; Lung; Pandemics; Pneumonia, Viral; Positive-Pressure Respiration; Respiratory Distress Syndrome; SARS-CoV-2; United States | 2020 |
SARS-CoV-2: Pathogenesis, and Advancements in Diagnostics and Treatment.
Topics: Adenosine Monophosphate; Alanine; Angiotensin-Converting Enzyme 2; Antibodies, Monoclonal; Antibodies, Viral; Antiviral Agents; Betacoronavirus; Clinical Laboratory Techniques; Coronavirus Infections; COVID-19; COVID-19 Testing; Disease Reservoirs; Drug Repositioning; Humans; Immunoenzyme Techniques; Immunotherapy; Pandemics; Peptidyl-Dipeptidase A; Pneumonia, Viral; Receptors, Virus; Reverse Transcriptase Polymerase Chain Reaction; SARS-CoV-2; Serologic Tests; Spike Glycoprotein, Coronavirus | 2020 |
Use of remdesivir in the presence of elevated LFTs for the treatment of severe COVID-19 infection.
Topics: Adenosine Monophosphate; Aged, 80 and over; Alanine; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Dexamethasone; Emergency Service, Hospital; Humans; Length of Stay; Liver Diseases; Liver Function Tests; Male; Pandemics; Patient Discharge; Pneumonia, Viral; Respiratory Insufficiency; Severity of Illness Index; Treatment Outcome | 2020 |
Major Update: Remdesivir for Adults With COVID-19 : A Living Systematic Review and Meta-analysis for the American College of Physicians Practice Points.
Topics: Adenosine Monophosphate; Adult; Alanine; Antiviral Agents; COVID-19 Drug Treatment; Humans; Pneumonia, Viral; SARS-CoV-2 | 2021 |
8 trial(s) available for adenosine monophosphate and Pneumonia, Viral
Article | Year |
---|---|
Compassionate remdesivir treatment of severe Covid-19 pneumonia in intensive care unit (ICU) and Non-ICU patients: Clinical outcome and differences in post-treatment hospitalisation status.
Topics: Acute Kidney Injury; Adenosine Monophosphate; Aged; Alanine; Antiviral Agents; Betacoronavirus; Compassionate Use Trials; Coronavirus Infections; COVID-19; Female; Hospitalization; Humans; Intensive Care Units; Male; Middle Aged; Pandemics; Pneumonia, Viral; SARS-CoV-2; Transaminases; Treatment Outcome | 2020 |
Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial.
Topics: Adenosine Monophosphate; Aged; Alanine; Antiviral Agents; Betacoronavirus; China; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Double-Blind Method; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Negative Results; Pandemics; Pneumonia, Viral; SARS-CoV-2 | 2020 |
Remdesivir for the Treatment of Covid-19 - Final Report.
Topics: Adenosine Monophosphate; Administration, Intravenous; Adult; Aged; Alanine; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Double-Blind Method; Extracorporeal Membrane Oxygenation; Female; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Oxygen Inhalation Therapy; Pandemics; Pneumonia, Viral; Respiration, Artificial; SARS-CoV-2; Time Factors; Young Adult | 2020 |
Evaluation of the efficacy and safety of intravenous remdesivir in adult patients with severe COVID-19: study protocol for a phase 3 randomized, double-blind, placebo-controlled, multicentre trial.
Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Betacoronavirus; China; Clinical Trials, Phase III as Topic; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Double-Blind Method; Equivalence Trials as Topic; Female; Humans; Infusions, Intravenous; Male; Multicenter Studies as Topic; Pandemics; Patient Safety; Pneumonia, Viral; Risk Assessment; Risk Factors; SARS-CoV-2; Severity of Illness Index; Time Factors; Treatment Outcome | 2020 |
Remdesivir for 5 or 10 Days in Patients with Severe Covid-19.
Topics: Adenosine Monophosphate; Adult; Aged; Alanine; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Drug Administration Schedule; Female; Hospitalization; Humans; Male; Middle Aged; Oxygen Inhalation Therapy; Pandemics; Pneumonia, Viral; SARS-CoV-2; Treatment Outcome | 2020 |
Safety, Tolerability, and Pharmacokinetics of Remdesivir, An Antiviral for Treatment of COVID-19, in Healthy Subjects.
Topics: Adenosine Monophosphate; Administration, Intravenous; Adult; Alanine; Antiviral Agents; Area Under Curve; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Female; Healthy Volunteers; Humans; Japan; Male; Middle Aged; Pandemics; Pneumonia, Viral; SARS-CoV-2; Young Adult | 2020 |
Effect of Remdesivir vs Standard Care on Clinical Status at 11 Days in Patients With Moderate COVID-19: A Randomized Clinical Trial.
Topics: Adenosine Monophosphate; Administration, Intravenous; Aged; Alanine; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Drug Administration Schedule; Female; Hospitalization; Humans; Male; Middle Aged; Odds Ratio; Pandemics; Patient Acuity; Pneumonia, Viral; SARS-CoV-2; Treatment Outcome | 2020 |
Protocol for the DisCoVeRy trial: multicentre, adaptive, randomised trial of the safety and efficacy of treatments for COVID-19 in hospitalised adults.
Topics: Adenosine Monophosphate; Adult; Alanine; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Drug Combinations; Drug Therapy, Combination; Early Warning Score; Extracorporeal Membrane Oxygenation; Hospital Mortality; Hospitalization; Humans; Hydroxychloroquine; Interferon beta-1a; Length of Stay; Lopinavir; Oxygen Inhalation Therapy; Pandemics; Pneumonia, Viral; Respiration, Artificial; Ritonavir; SARS-CoV-2; Standard of Care; Treatment Outcome | 2020 |
158 other study(ies) available for adenosine monophosphate and Pneumonia, Viral
Article | Year |
---|---|
SARS-CoV-2 Infection in an Adolescent With X-linked Agammaglobulinemia.
Topics: Adenosine Monophosphate; Adolescent; Agammaglobulinemia; Alanine; Antibodies, Viral; Antiviral Agents; Biomarkers; Bronchoalveolar Lavage Fluid; COVID-19; COVID-19 Drug Treatment; Fever; Genetic Diseases, X-Linked; Humans; Inflammation; Male; Pneumonia, Viral; SARS-CoV-2 | 2021 |
Nirmatrelvir-remdesivir association for non-hospitalized adults with COVID-19, point of view.
Topics: Adenosine Monophosphate; Adult; Alanine; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19 Drug Treatment; Hospitalization; Humans; Pandemics; Pneumonia, Viral; SARS-CoV-2 | 2022 |
Remdesivir-induced emergence of SARS-CoV2 variants in patients with prolonged infection.
Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19 Drug Treatment; Disease Progression; Humans; Pandemics; Pneumonia, Viral; RNA-Dependent RNA Polymerase; RNA, Viral; SARS-CoV-2 | 2022 |
Drug treatment options for the 2019-new coronavirus (2019-nCoV).
Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Drug Combinations; Drug Discovery; Humans; Lopinavir; Neuraminidase; Nucleosides; Pneumonia, Viral; Ribonucleotides; Ritonavir; SARS-CoV-2 | 2020 |
Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro.
Topics: Adenosine Monophosphate; Alanine; Animals; Antimalarials; Antiviral Agents; Betacoronavirus; Biological Assay; Chlorocebus aethiops; Chloroquine; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Drug Discovery; Drug Evaluation, Preclinical; Humans; Middle East Respiratory Syndrome Coronavirus; Pneumonia, Viral; SARS-CoV-2; Severe acute respiratory syndrome-related coronavirus; Sincalide; Vero Cells | 2020 |
Prophylactic and therapeutic remdesivir (GS-5734) treatment in the rhesus macaque model of MERS-CoV infection.
Topics: Adenosine Monophosphate; Alanine; Animals; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; Disease Models, Animal; Lung; Macaca mulatta; Male; Middle East Respiratory Syndrome Coronavirus; Pandemics; Pneumonia, Viral; Post-Exposure Prophylaxis; SARS-CoV-2; Viral Load; Virus Replication | 2020 |
More than 80 clinical trials launch to test coronavirus treatments.
Topics: Adenosine Monophosphate; Alanine; Animals; Anti-HIV Agents; Betacoronavirus; China; Chloroquine; Clinical Trials as Topic; Coronavirus Infections; COVID-19; COVID-19 Serotherapy; Dioxanes; Disease Models, Animal; Drug Combinations; Humans; Immunization, Passive; Lopinavir; Medicine, Chinese Traditional; Monosaccharides; Pandemics; Pneumonia, Viral; Registries; Ritonavir; SARS-CoV-2; Severe Acute Respiratory Syndrome; Stem Cell Transplantation; Steroids; Time Factors; Treatment Outcome; World Health Organization | 2020 |
Anti-HCV, nucleotide inhibitors, repurposing against COVID-19.
Topics: Adenosine Monophosphate; Alanine; Alphacoronavirus; Amino Acid Sequence; Antiviral Agents; Betacoronavirus; Catalytic Domain; Computational Biology; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Drug Repositioning; Guanosine Monophosphate; Guanosine Triphosphate; Humans; Molecular Docking Simulation; Pneumonia, Viral; Protein Binding; Protein Conformation, alpha-Helical; Protein Conformation, beta-Strand; Protein Interaction Domains and Motifs; Ribavirin; RNA-Dependent RNA Polymerase; SARS-CoV-2; Sequence Alignment; Sequence Homology, Amino Acid; Sofosbuvir; Thermodynamics; Uridine Triphosphate; Viral Proteins | 2020 |
Therapeutic options for the 2019 novel coronavirus (2019-nCoV).
Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Drug Repositioning; Hepatitis B; Hepatitis C; HIV Infections; Humans; Influenza, Human; Interferon-alpha; Middle East Respiratory Syndrome Coronavirus; Nucleosides; Pneumonia, Viral; Polyethylene Glycols; Protease Inhibitors; Recombinant Proteins; SARS-CoV-2; Severe acute respiratory syndrome-related coronavirus; Spike Glycoprotein, Coronavirus | 2020 |
Breastfeeding and Respiratory Antivirals: Coronavirus and Influenza.
Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Betacoronavirus; Breast Feeding; Coronavirus Infections; COVID-19; Female; Humans; Infant; Infant, Newborn; Influenza, Human; Milk, Human; Pandemics; Pneumonia, Viral; SARS-CoV-2 | 2020 |
Chloroquine and hydroxychloroquine as available weapons to fight COVID-19.
Topics: Adenosine Monophosphate; Alanine; Betacoronavirus; Chloroquine; Coronavirus; Coronavirus Infections; COVID-19; Hydroxychloroquine; Pandemics; Pneumonia, Viral; SARS-CoV-2 | 2020 |
Arguments in favour of remdesivir for treating SARS-CoV-2 infections.
Topics: Adenosine Monophosphate; Alanine; Animals; Antiviral Agents; Betacoronavirus; Clinical Trials as Topic; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; DNA-Directed RNA Polymerases; Humans; Pandemics; Pneumonia, Viral; SARS-CoV-2 | 2020 |
Discovering drugs to treat coronavirus disease 2019 (COVID-19).
Topics: Adenosine Monophosphate; Alanine; Amides; Antiviral Agents; Betacoronavirus; Chloroquine; Clinical Studies as Topic; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Drug Discovery; Humans; Indoles; Pandemics; Pneumonia, Viral; Pyrazines; Ribonucleotides; SARS-CoV-2; Virus Replication | 2020 |
Advance of promising targets and agents against COVID-19 in China.
Topics: Adenine; Adenosine Monophosphate; Alanine; Amides; Antimalarials; Antiviral Agents; Betacoronavirus; China; Chloroquine; Clinical Trials as Topic; Cobicistat; Coronavirus 3C Proteases; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Cysteine Endopeptidases; Dibenzothiepins; Drug Combinations; Drug Discovery; Drug Therapy, Combination; Emtricitabine; Humans; Hydroxychloroquine; Indoles; Lopinavir; Medicine, Chinese Traditional; Morpholines; Oseltamivir; Oxazines; Pandemics; Pneumonia, Viral; Pyrazines; Pyridines; Pyridones; Ritonavir; RNA-Dependent RNA Polymerase; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Tenofovir; Thiepins; Triazines; Viral Nonstructural Proteins | 2020 |
Are there any Therapeutic Options Currently Available for Wuhan Coronavirus?
Topics: Adenosine Monophosphate; Alanine; Angiotensin-Converting Enzyme 2; Antiviral Agents; Betacoronavirus; Chloroquine; Communicable Disease Control; Coronavirus Infections; COVID-19; Drug Discovery; Drug Repositioning; Humans; Pandemics; Peptidyl-Dipeptidase A; Pneumonia, Viral; SARS-CoV-2; Virus Internalization | 2020 |
Expanded Umbilical Cord Mesenchymal Stem Cells (UC-MSCs) as a Therapeutic Strategy in Managing Critically Ill COVID-19 Patients: The Case for Compassionate Use.
Topics: Adenosine Monophosphate; Alanine; Analgesia; Antiviral Agents; Betacoronavirus; China; Compassionate Use Trials; Cord Blood Stem Cell Transplantation; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; COVID-19 Vaccines; Critical Illness; Cytokines; Humans; Hydroxychloroquine; Mesenchymal Stem Cell Transplantation; Pandemics; Pneumonia, Viral; SARS-CoV-2; Umbilical Cord; United States; Viral Vaccines | 2020 |
Race to find COVID-19 treatments accelerates.
Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Betacoronavirus; Biomedical Research; Chloroquine; Clinical Trials as Topic; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Drug Combinations; Humans; Hydroxychloroquine; Lopinavir; Pandemics; Pneumonia, Viral; Ritonavir; SARS-CoV-2; World Health Organization | 2020 |
To consider or not antimalarials as a prophylactic intervention in the SARS-CoV-2 (Covid-19) pandemic.
Topics: Adenosine Monophosphate; Alanine; Antimalarials; Betacoronavirus; Chloroquine; Coronavirus; Coronavirus Infections; COVID-19; Pandemics; Pneumonia, Viral; SARS-CoV-2; Severe acute respiratory syndrome-related coronavirus | 2020 |
Remdesivir, lopinavir, emetine, and homoharringtonine inhibit SARS-CoV-2 replication in vitro.
Topics: Adenosine Monophosphate; Alanine; Amides; Animals; Antimetabolites; Antiviral Agents; Betacoronavirus; Chlorocebus aethiops; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Drug Combinations; Emetine; Epithelial Cells; Homoharringtonine; Humans; Lopinavir; Pandemics; Pneumonia, Viral; Pyrazines; Ribavirin; SARS-CoV-2; Vero Cells; Virus Replication | 2020 |
An orally bioavailable broad-spectrum antiviral inhibits SARS-CoV-2 in human airway epithelial cell cultures and multiple coronaviruses in mice.
Topics: Adenosine Monophosphate; Alanine; Animals; Antibiotic Prophylaxis; Antiviral Agents; Betacoronavirus; Cell Line; Coronavirus Infections; COVID-19; Cytidine; Disease Models, Animal; Drug Resistance, Viral; Humans; Hydroxylamines; Lung; Mice; Mice, Inbred C57BL; Middle East Respiratory Syndrome Coronavirus; Models, Molecular; Mutation; Pandemics; Pneumonia, Viral; Primary Cell Culture; Random Allocation; Respiratory System; Ribonucleosides; RNA-Dependent RNA Polymerase; RNA, Viral; SARS-CoV-2; Virus Replication | 2020 |
Compassionate Use of Remdesivir for Patients with Severe Covid-19.
Topics: Adenosine Monophosphate; Administration, Intravenous; Adult; Aged; Aged, 80 and over; Alanine; Antiviral Agents; Betacoronavirus; Canada; Compassionate Use Trials; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Europe; Female; Humans; Japan; Male; Middle Aged; Pandemics; Pneumonia, Viral; Respiration, Artificial; SARS-CoV-2; United States; Young Adult | 2020 |
Delayed Initiation of Remdesivir in a COVID-19-Positive Patient.
Topics: Adenosine Monophosphate; Adult; Alanine; Antimalarials; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; Humans; Hydroxychloroquine; Male; Pandemics; Pneumonia, Viral; SARS-CoV-2; Time Factors; Time-to-Treatment | 2020 |
Coronavirus Disease (COVID-19) Pandemic: A Race Against Time.
Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Betacoronavirus; Clinical Trials as Topic; Coronavirus Infections; COVID-19; COVID-19 Vaccines; Hand Hygiene; Humans; International Cooperation; Masks; Pandemics; Patient Education as Topic; Pneumonia, Viral; Quarantine; SARS-CoV-2; Viral Vaccines | 2020 |
Early impact of COVID-19 on transplant center practices and policies in the United States.
Topics: Adenosine Monophosphate; Alanine; Antibodies, Monoclonal, Humanized; Betacoronavirus; Clinical Laboratory Techniques; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; COVID-19 Testing; Critical Illness; Evidence-Based Medicine; Health Policy; Humans; Hydroxychloroquine; Incidence; Kidney Failure, Chronic; Kidney Transplantation; Liver Transplantation; Living Donors; Organ Transplantation; Pandemics; Pneumonia, Viral; Resource Allocation; SARS-CoV-2; Surveys and Questionnaires; Tissue Donors; Transplant Recipients; United States | 2020 |
Remdesivir and SARS-CoV-2: Structural requirements at both nsp12 RdRp and nsp14 Exonuclease active-sites.
Topics: Adenosine Monophosphate; Alanine; Antimetabolites; Antiviral Agents; Betacoronavirus; Catalytic Domain; Coronavirus Infections; Coronavirus RNA-Dependent RNA Polymerase; COVID-19; Drug Resistance, Viral; Exoribonucleases; Humans; Models, Molecular; Mutation; Pandemics; Pneumonia, Viral; Protein Conformation; RNA-Dependent RNA Polymerase; RNA, Viral; SARS-CoV-2; Structure-Activity Relationship; Viral Nonstructural Proteins | 2020 |
SARS-CoV-2: Recent Reports on Antiviral Therapies Based on Lopinavir/Ritonavir, Darunavir/Umifenovir, Hydroxychloroquine, Remdesivir, Favipiravir and other Drugs for the Treatment of the New Coronavirus.
Topics: Adenosine Monophosphate; Alanine; Amides; Antiviral Agents; Betacoronavirus; China; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Darunavir; Drug Combinations; Humans; Hydroxychloroquine; Indoles; Lopinavir; Pandemics; Pneumonia, Viral; Pyrazines; Ritonavir; SARS-CoV-2 | 2020 |
COVID-2019: update on epidemiology, disease spread and management.
Topics: Adenosine Monophosphate; Alanine; Angiotensin-Converting Enzyme 2; Antiviral Agents; Basic Reproduction Number; Betacoronavirus; Clinical Laboratory Techniques; Clinical Trials as Topic; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; COVID-19 Testing; Humans; Pandemics; Peptidyl-Dipeptidase A; Pneumonia, Viral; Quarantine; Receptors, Virus; SARS-CoV-2 | 2020 |
The race against COVID-19.
Topics: Adenosine Monophosphate; Alanine; Antibodies, Viral; Antiviral Agents; Betacoronavirus; Clinical Laboratory Techniques; Clinical Trials as Topic; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; COVID-19 Testing; COVID-19 Vaccines; Humans; Hydroxychloroquine; Nucleic Acid Amplification Techniques; Pandemics; Pneumonia, Viral; SARS-CoV-2; Viral Vaccines | 2020 |
COVID-19 in a high-risk dual heart and kidney transplant recipient.
Topics: Adenosine Monophosphate; Adult; Alanine; Betacoronavirus; Cardiomyopathy, Dilated; Coronavirus Infections; COVID-19; Heart Transplantation; Humans; Hydroxychloroquine; Immunocompromised Host; Immunosuppression Therapy; Immunosuppressive Agents; Kidney Failure, Chronic; Kidney Transplantation; Male; Pandemics; Pneumonia, Viral; Radiography, Thoracic; Randomized Controlled Trials as Topic; Risk Factors; SARS-CoV-2; Treatment Outcome | 2020 |
Remdesivir in covid-19.
Topics: Adenosine Monophosphate; Alanine; Betacoronavirus; Compassionate Use Trials; Coronavirus Infections; COVID-19; Humans; Pandemics; Pneumonia, Viral; Ribonucleotides; SARS-CoV-2 | 2020 |
Some drugs for COVID-19.
Topics: Adenosine Monophosphate; Adrenal Cortex Hormones; Alanine; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Anti-Inflammatory Agents, Non-Steroidal; Azithromycin; Betacoronavirus; Chloroquine; Clinical Trials as Topic; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; COVID-19 Serotherapy; Drug Combinations; Drug Repositioning; Humans; Hydroxychloroquine; Immunization, Passive; Lopinavir; Neuraminidase; Pandemics; Pneumonia, Viral; Ritonavir; SARS-CoV-2 | 2020 |
Vaporization, bioactive formulations and a marine natural product: different perspectives on antivirals.
Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Aquatic Organisms; Biological Products; Chloroquine; Coronavirus Infections; COVID-19; Drug Compounding; Humans; Hydroxychloroquine; Models, Molecular; Pandemics; Pneumonia, Viral; Volatilization | 2020 |
COVID-19 in solid organ transplant recipients: Initial report from the US epicenter.
Topics: Adenosine Monophosphate; Adult; Aged; Alanine; Antibodies, Monoclonal, Humanized; Antiviral Agents; Azithromycin; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Critical Care; Female; Hospitalization; Humans; Hydroxychloroquine; Immunosuppression Therapy; Immunosuppressive Agents; Intensive Care Units; Intubation; Male; Middle Aged; New York City; Organ Transplantation; Pandemics; Pneumonia, Viral; Respiration, Artificial; SARS-CoV-2; Steroids; Transplant Recipients; Treatment Outcome; United States | 2020 |
Chloroquine hype is derailing the search for coronavirus treatments.
Topics: Adenosine Monophosphate; Alanine; Betacoronavirus; Chloroquine; Coronavirus; Coronavirus Infections; COVID-19; Humans; Pandemics; Pneumonia, Viral; SARS-CoV-2 | 2020 |
The clinical manifestations and management of COVID-19-related liver injury.
Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; Humans; Liver; Liver Diseases; Liver Function Tests; Pandemics; Pneumonia, Viral; SARS-CoV-2 | 2020 |
Chloroquine and hydroxychloroquine for COVID-19: implications for cardiac safety.
Topics: Adenosine Monophosphate; Alanine; Betacoronavirus; Chloroquine; Coronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Humans; Hydroxychloroquine; Pandemics; Pneumonia, Viral; SARS-CoV-2 | 2020 |
Liu Shen capsule shows antiviral and anti-inflammatory abilities against novel coronavirus SARS-CoV-2 via suppression of NF-κB signaling pathway.
Topics: Adenosine Monophosphate; Alanine; Animals; Anti-Inflammatory Agents; Antiviral Agents; Betacoronavirus; Cell Proliferation; Cells, Cultured; Chlorocebus aethiops; Complex Mixtures; Coronavirus Infections; COVID-19; Humans; Inflammation Mediators; NF-kappa B; Pandemics; Pneumonia, Viral; SARS-CoV-2; Signal Transduction; Virion | 2020 |
Development and validation of a UHPLC-MS/MS method for quantification of the prodrug remdesivir and its metabolite GS-441524: a tool for clinical pharmacokinetics of SARS-CoV-2/COVID-19 and Ebola virus disease.
Topics: Adenosine Monophosphate; Adenosine Triphosphate; Alanine; Betacoronavirus; Chromatography, High Pressure Liquid; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Hemorrhagic Fever, Ebola; Humans; Pandemics; Pneumonia, Viral; SARS-CoV-2; Sensitivity and Specificity; Tandem Mass Spectrometry | 2020 |
The lysosome: A potential juncture between SARS-CoV-2 infectivity and Niemann-Pick disease type C, with therapeutic implications.
Topics: ADAM17 Protein; Adenosine Monophosphate; Alanine; Angiotensin-Converting Enzyme 2; Antiviral Agents; Benzylisoquinolines; Betacoronavirus; Biological Transport; Cathepsin L; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Drug Repositioning; Endocytosis; Endosomes; Glycopeptides; Humans; Hydroxychloroquine; Intracellular Signaling Peptides and Proteins; Lysosomes; Membrane Lipids; Membrane Microdomains; Niemann-Pick C1 Protein; Niemann-Pick Disease, Type C; Oxysterols; Pandemics; Peptidyl-Dipeptidase A; Pneumonia, Viral; Receptors, Virus; SARS-CoV-2; Serine Endopeptidases; Triazoles; Virus Internalization | 2020 |
Audio Interview: Studying Potential Covid-19 Therapies.
Topics: Adenosine Monophosphate; Alanine; Anti-Infective Agents; Azithromycin; Betacoronavirus; Controlled Clinical Trials as Topic; Coronavirus Infections; COVID-19; Drug Therapy, Combination; Humans; Hydroxychloroquine; Observational Studies as Topic; Pandemics; Pneumonia, Viral; Research Design; SARS-CoV-2 | 2020 |
When the Others Become Us: A Chemist's Perspective of the COVID-19 Outbreak in Italy.
Topics: Adenosine Monophosphate; Alanine; Antibodies, Monoclonal, Humanized; Betacoronavirus; Biomedical Research; Chemistry; Clinical Trials as Topic; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Humans; Italy; Laboratories; Pandemics; Phylogeny; Pneumonia, Viral; SARS-CoV-2 | 2020 |
Novel coronavirus 2019 (COVID-19): A case report and review of treatments.
Topics: Adenosine Monophosphate; Aged; Alanine; Antimalarials; Antiviral Agents; Betacoronavirus; Clinical Laboratory Techniques; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; COVID-19 Testing; Fatal Outcome; Female; Humans; Hydroxychloroquine; Pandemics; Pneumonia, Viral; Respiratory Distress Syndrome; SARS-CoV-2 | 2020 |
[Chloroquine as a possible treatment for COVID-19].
Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Betacoronavirus; Chloroquine; Coronavirus Infections; COVID-19; Humans; Lopinavir; Off-Label Use; Pandemics; Pneumonia, Viral; Ritonavir; SARS-CoV-2; Treatment Outcome | 2020 |
[The "Historic Study" SOLIDARITY-Research's Answer to the Sars-CoV-2 Pandemic].
Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Betacoronavirus; Bioethical Issues; Chloroquine; Clinical Trials as Topic; Coronavirus Infections; COVID-19; Drug Combinations; Editorial Policies; Humans; Hydroxychloroquine; International Cooperation; Lopinavir; Pandemics; Pneumonia, Viral; Research Design; Ritonavir; SARS-CoV-2; World Health Organization | 2020 |
In Vitro Data of Current Therapies for SARS-CoV-2.
Topics: Adenosine Monophosphate; Alanine; Betacoronavirus; China; Chloroquine; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Drug Repositioning; Emetine; Homoharringtonine; Humans; Hydroxychloroquine; Ivermectin; Lopinavir; Nitro Compounds; Pandemics; Pneumonia, Viral; SARS-CoV-2; Teicoplanin; Thiazoles | 2020 |
Case 17-2020: A 68-Year-Old Man with Covid-19 and Acute Kidney Injury.
Topics: Acute Kidney Injury; Adenosine Monophosphate; Aged; Alanine; Amides; Anti-Inflammatory Agents; Anticoagulants; Antiviral Agents; Betacoronavirus; Continuous Renal Replacement Therapy; Coronavirus Infections; COVID-19; Creatinine; Humans; Hypertension; Lung; Male; Obesity; Pandemics; Pneumonia, Viral; Pyrazines; Radiography, Thoracic; SARS-CoV-2 | 2020 |
Coronavirus drugs trials must get bigger and more collaborative.
Topics: Adenosine Monophosphate; Alanine; Betacoronavirus; Compassionate Use Trials; Coronavirus; Coronavirus Infections; COVID-19; Humans; Pandemics; Pneumonia, Viral; SARS-CoV-2 | 2020 |
Characteristics and Outcomes of Coronavirus Disease Patients under Nonsurge Conditions, Northern California, USA, March-April 2020.
Topics: Adenosine Monophosphate; Aged; Aged, 80 and over; Alanine; Asthma; Azithromycin; Betacoronavirus; California; Clinical Laboratory Techniques; Comorbidity; Coronavirus Infections; COVID-19; COVID-19 Testing; Diabetes Mellitus; Female; Humans; Hyperlipidemias; Hypertension; Intensive Care Units; Length of Stay; Male; Pandemics; Pneumonia, Viral; Pulmonary Disease, Chronic Obstructive; Retrospective Studies; Reverse Transcriptase Polymerase Chain Reaction; SARS-CoV-2; Severity of Illness Index; Survival Analysis; Tomography, X-Ray Computed | 2020 |
Emergency Use Authorization of Remdesivir: The Need for a Transparent Distribution Process.
Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Drug Approval; Emergencies; Humans; Pandemics; Pneumonia, Viral; SARS-CoV-2; United States | 2020 |
Clinical Characteristics and Outcomes of Hospitalized and Critically Ill Children and Adolescents with Coronavirus Disease 2019 at a Tertiary Care Medical Center in New York City.
Topics: Adenosine Monophosphate; Adolescent; Alanine; Antiviral Agents; Asthma; Betacoronavirus; Blood Urea Nitrogen; C-Reactive Protein; Child; Child, Preschool; Coronavirus Infections; COVID-19; Creatinine; Critical Illness; Dyspnea; Female; Hospitalization; Hospitals, Pediatric; Humans; Infant; Infant, Newborn; Intensive Care Units, Pediatric; Male; Natriuretic Peptide, Brain; New York City; Pandemics; Pediatric Obesity; Platelet Count; Pneumonia, Viral; Procalcitonin; Respiration, Artificial; Retrospective Studies; SARS-CoV-2; Sepsis; Shock, Septic; Tertiary Care Centers; Young Adult | 2020 |
Dozens of coronavirus drugs are in development - what happens next?
Topics: Adenosine Monophosphate; Alanine; Antibodies, Monoclonal, Humanized; Antiviral Agents; Coronavirus Infections; COVID-19; Drug Development; Drug Industry; Humans; Hydroxychloroquine; Oseltamivir; Pandemics; Pneumonia, Viral | 2020 |
Compassionate Use of Remdesivir in Covid-19.
Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Betacoronavirus; Compassionate Use Trials; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Humans; Pandemics; Pneumonia, Viral; SARS-CoV-2 | 2020 |
Compassionate Use of Remdesivir in Covid-19.
Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Betacoronavirus; Compassionate Use Trials; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Humans; Pandemics; Pneumonia, Viral; SARS-CoV-2 | 2020 |
Compassionate Use of Remdesivir in Covid-19.
Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Betacoronavirus; Compassionate Use Trials; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Humans; Pandemics; Pneumonia, Viral; SARS-CoV-2 | 2020 |
Compassionate Use of Remdesivir in Covid-19.
Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Betacoronavirus; Compassionate Use Trials; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Humans; Pandemics; Pneumonia, Viral; SARS-CoV-2 | 2020 |
Compassionate Use of Remdesivir in Covid-19. Reply.
Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Betacoronavirus; Compassionate Use Trials; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Humans; Pandemics; Pneumonia, Viral; SARS-CoV-2 | 2020 |
Early experience with remdesivir in SARS-CoV-2 pneumonia.
Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Betacoronavirus; Chemical and Drug Induced Liver Injury; Convalescence; Coronavirus Infections; COVID-19; Critical Illness; Darunavir; Drug Administration Schedule; Drug Combinations; Fatal Outcome; Humans; Hydroxychloroquine; Lopinavir; Multiple Organ Failure; Pandemics; Pneumonia, Viral; Ritonavir; RNA, Viral; SARS-CoV-2; Torsades de Pointes | 2020 |
Protect Pregnant and Lactating Women with COVID-19 Through Research, Not from Research.
Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Betacoronavirus; Breast Feeding; Coronavirus Infections; COVID-19; Drug Approval; Female; Humans; Infant Nutritional Physiological Phenomena; Infant, Newborn; Infectious Disease Transmission, Vertical; Lactation; Milk, Human; Pandemics; Pneumonia, Viral; Pregnancy; Risk Assessment; SARS-CoV-2 | 2020 |
Interleukin-1 receptor antagonist anakinra in association with remdesivir in severe COVID-19: A case report.
Topics: Adenosine Monophosphate; Alanine; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Drug Combinations; Humans; Interleukin 1 Receptor Antagonist Protein; Male; Middle Aged; Pandemics; Pneumonia, Viral; Receptors, Interleukin-1; Respiratory Insufficiency; SARS-CoV-2 | 2020 |
[From empiricism to scientific evidence in antiviral treatment in severe cases of coronavirus infection in times of epidemic].
Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Betacoronavirus; Chloroquine; Clinical Decision-Making; Clinical Trials as Topic; Coronavirus Infections; Cost-Benefit Analysis; COVID-19; Drug Combinations; Empiricism; Humans; Hydroxychloroquine; Information Dissemination; Lopinavir; Pandemics; Pneumonia, Viral; Reproducibility of Results; Ritonavir; SARS-CoV-2; Viral Load | 2020 |
Remdesivir for COVID-19: challenges of underpowered studies.
Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; Double-Blind Method; Pandemics; Pneumonia, Viral; Randomized Controlled Trials as Topic; SARS-CoV-2 | 2020 |
Does lopinavir really inhibit SARS-CoV-2?
Topics: Adenosine Monophosphate; Alanine; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Emetine; Homoharringtonine; Humans; Lopinavir; Pandemics; Pneumonia, Viral; SARS-CoV-2; Severe acute respiratory syndrome-related coronavirus | 2020 |
5-Fluorouracil in combination with deoxyribonucleosides and deoxyribose as possible therapeutic options for the Coronavirus, COVID-19 infection.
Topics: Adenosine Monophosphate; Alanine; Betacoronavirus; Chloroquine; Clinical Trials as Topic; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Deoxyribonucleosides; Deoxyribose; Drug Administration Schedule; Drug Synergism; Fluorouracil; Humans; Inflammation; Models, Theoretical; Pandemics; Pneumonia, Viral; SARS-CoV-2 | 2020 |
Probable Molecular Mechanism of Remdesivir for the Treatment of COVID-19: Need to Know More.
Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Humans; Pandemics; Pneumonia, Viral; RNA, Viral; SARS-CoV-2 | 2020 |
Remdesivir for Treatment of COVID-19: Combination of Pulmonary and IV Administration May Offer Aditional Benefit.
Topics: Adenosine Monophosphate; Administration, Inhalation; Administration, Intravenous; Alanine; Animals; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; Humans; Pandemics; Pneumonia, Viral; SARS-CoV-2 | 2020 |
Remdesivir - An Important First Step.
Topics: Adenosine Monophosphate; Alanine; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Humans; Pandemics; Pneumonia, Viral; SARS-CoV-2 | 2020 |
Audio Interview: New Data on Remdesivir in Covid-19.
Topics: Adenosine Monophosphate; Adult; Alanine; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; Drug Administration Schedule; Drug Evaluation; Humans; Hydroxychloroquine; Infusions, Intravenous; Pandemics; Placebos; Pneumonia, Viral; Randomized Controlled Trials as Topic; SARS-CoV-2; Time Factors; Treatment Outcome; Viral Load | 2020 |
Remdesivir and Potential Interactions With Psychotropic Medications: A COVID-19 Perspective.
Topics: Adenosine Monophosphate; Alanine; Betacoronavirus; Coronavirus Infections; COVID-19; Drug Interactions; Humans; Pandemics; Pneumonia, Viral; Psychotropic Drugs; SARS-CoV-2 | 2020 |
An update on novel COVID-19 pandemic: a battle between humans and virus.
Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; Humans; Pandemics; Pneumonia, Viral; Respiratory Distress Syndrome; RNA, Viral; SARS-CoV-2; Survival Analysis | 2020 |
Simulated Assessment of Pharmacokinetically Guided Dosing for Investigational Treatments of Pediatric Patients With Coronavirus Disease 2019.
Topics: Adenosine Monophosphate; Adolescent; Adult; Alanine; Antiviral Agents; Child; Child, Preschool; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Drug Administration Schedule; Drug Dosage Calculations; Female; Humans; Hydroxychloroquine; Infant; Infant, Newborn; Male; Models, Biological; Pandemics; Patient Simulation; Pneumonia, Viral; Therapies, Investigational; Young Adult | 2020 |
Efficacy of remdesivir in patients with COVID-19: a protocol for systematic review and meta-analysis of randomised controlled trials.
Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; Humans; Infection Control; Meta-Analysis as Topic; Pandemics; Pneumonia, Viral; Research Design; SARS-CoV-2; Systematic Reviews as Topic; Treatment Outcome | 2020 |
[Remdesivir til behandling af COVID-19-pneumoni].
Topics: Adenosine Monophosphate; Alanine; Betacoronavirus; Coronavirus Infections; COVID-19; Humans; Pandemics; Pneumonia, Viral; SARS-CoV-2 | 2020 |
Clinical benefit of remdesivir in rhesus macaques infected with SARS-CoV-2.
Topics: Adenosine Monophosphate; Alanine; Animals; Betacoronavirus; Bronchoalveolar Lavage Fluid; Coronavirus Infections; COVID-19; Disease Models, Animal; Disease Progression; DNA Mutational Analysis; Drug Resistance, Viral; Female; Lung; Macaca mulatta; Male; Pandemics; Pneumonia, Viral; SARS-CoV-2; Secondary Prevention; Time Factors; Viral Load; Virus Replication; Virus Shedding | 2020 |
Topics: Adenosine Monophosphate; Alanine; Betacoronavirus; Clinical Trials as Topic; Coronavirus Infections; COVID-19; Humans; Negative Results; Pandemics; Pneumonia, Viral; SARS-CoV-2 | 2020 |
Flight of the COVID-19 patient: experience with a Wuhan evacuee: a case report.
Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Betacoronavirus; Blood Cell Count; California; China; Clinical Laboratory Techniques; Coronavirus Infections; COVID-19; COVID-19 Testing; Disease Transmission, Infectious; Female; Humans; Liver Function Tests; Middle Aged; Pandemics; Pneumonia, Viral; Quarantine; Radiography, Thoracic; SARS-CoV-2; Treatment Outcome | 2020 |
The rationale for Low-Molecular Weight Heparin (LMWH) use in SARS-CoV-2 infection
Topics: Adenosine Monophosphate; Alanine; Anticoagulants; Antiviral Agents; Biomarkers; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Critical Care; Disease Management; Double-Blind Method; Drug Combinations; Drug Therapy, Combination; Embolism; Endothelium, Vascular; Heparin, Low-Molecular-Weight; Humans; Hydroxychloroquine; Interferon beta-1b; Lopinavir; Macrophage Activation; Pandemics; Pneumonia, Viral; Pulmonary Fibrosis; Randomized Controlled Trials as Topic; Ritonavir; Thromboembolism; Thrombophilia; Thrombosis | 2020 |
Uncertainty about the Efficacy of Remdesivir on COVID-19.
Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; Drug Repositioning; Humans; Pandemics; Pneumonia, Viral; RNA-Dependent RNA Polymerase; SARS-CoV-2; Uncertainty; Virus Replication | 2020 |
Coronavirus breakthrough: dexamethasone is first drug shown to save lives.
Topics: Adenosine Monophosphate; Alanine; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Critical Illness; Dexamethasone; Humans; Pandemics; Pneumonia, Viral; Preprints as Topic; Randomized Controlled Trials as Topic; Respiration, Artificial; Risk Assessment; Survival Rate | 2020 |
A Case of Breakthrough COVID-19 during Hydroxychloroquine Maintenance.
Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Azithromycin; Betacoronavirus; Coronavirus Infections; COVID-19; Female; Humans; Hydroxychloroquine; Middle Aged; Pandemics; Pneumonia, Viral; Primary Prevention; SARS-CoV-2 | 2020 |
[Remdesivir for patients with COVID-19].
Topics: Adenosine Monophosphate; Alanine; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Humans; Pandemics; Pneumonia, Viral; SARS-CoV-2 | 2020 |
Quantification of plasma remdesivir and its metabolite GS-441524 using liquid chromatography coupled to tandem mass spectrometry. Application to a Covid-19 treated patient.
Topics: Adenosine; Adenosine Monophosphate; Alanine; Antiviral Agents; Betacoronavirus; Chromatography, Liquid; Coronavirus Infections; COVID-19; Drug Monitoring; Drug Stability; Female; Furans; Humans; Limit of Detection; Male; Middle Aged; Pandemics; Pneumonia, Viral; Pyrroles; Reproducibility of Results; SARS-CoV-2; Tandem Mass Spectrometry; Triazines | 2020 |
A Proposed Lottery System to Allocate Scarce COVID-19 Medications: Promoting Fairness and Generating Knowledge.
Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Drug Approval; Health Care Rationing; Humans; Pandemics; Pneumonia, Viral; Resource Allocation; SARS-CoV-2; State Government | 2020 |
Missed Opportunities on Emergency Remdesivir Use.
Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Betacoronavirus; Clinical Trials, Phase III as Topic; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Drug Approval; Drug Costs; Drugs, Investigational; Hemorrhagic Fever, Ebola; Humans; Length of Stay; National Institute of Allergy and Infectious Diseases (U.S.); Pandemics; Pneumonia, Viral; Registries; SARS-CoV-2; Treatment Outcome; United States | 2020 |
Validity of the UK early access to medicines scheme criteria for Remdesivir use in patients with COVID-19 disease.
Topics: Adenosine Monophosphate; Alanine; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Health Services Accessibility; Humans; London; Pandemics; Pneumonia, Viral; Retrospective Studies; SARS-CoV-2; State Medicine; United Kingdom | 2020 |
Optimizing Medication Management During the COVID-19 Pandemic: It Takes a Village.
Topics: Adenosine Monophosphate; Alanine; Betacoronavirus; Coronavirus Infections; COVID-19; Drug Therapy; Humans; Hydroxychloroquine; Nurse-Patient Relations; Nursing Homes; Pandemics; Pneumonia, Viral; Prodrugs; SARS-CoV-2 | 2020 |
Pharmacokinetics of remdesivir and GS-441524 in two critically ill patients who recovered from COVID-19.
Topics: Adenosine Monophosphate; Adenosine Triphosphate; Aged; Alanine; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; Critical Illness; Female; Humans; Male; Pandemics; Pneumonia, Viral; Recovery of Function; SARS-CoV-2 | 2020 |
Phylogenetic Analysis and Structural Perspectives of RNA-Dependent RNA-Polymerase Inhibition from SARs-CoV-2 with Natural Products.
Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Betacoronavirus; Biological Products; Catalytic Domain; Computer Simulation; Coronavirus Infections; Coronavirus RNA-Dependent RNA Polymerase; COVID-19; Databases, Pharmaceutical; Drug Evaluation, Preclinical; Genome, Viral; Host Microbial Interactions; Humans; Ligands; Molecular Docking Simulation; Pandemics; Phylogeny; Pneumonia, Viral; RNA-Dependent RNA Polymerase; SARS-CoV-2; Viral Nonstructural Proteins | 2020 |
Tocilizumab and Remdesivir in a Pregnant Patient With Coronavirus Disease 2019 (COVID-19).
Topics: Adenosine Monophosphate; Adult; Alanine; Antibodies, Monoclonal, Humanized; Antiviral Agents; Betacoronavirus; C-Reactive Protein; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Female; Humans; Interleukin-6; Lung; Oximetry; Pandemics; Pneumonia, Viral; Pregnancy; Pregnancy Complications, Infectious; Radiography, Thoracic; SARS-CoV-2; Treatment Outcome | 2020 |
Case report study of the first five COVID-19 patients treated with remdesivir in France.
Topics: Adenosine Monophosphate; Adult; Aged; Aged, 80 and over; Alanine; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; Female; France; Hospitalization; Humans; Male; Pandemics; Pneumonia, Viral; SARS-CoV-2; Viral Load; Withholding Treatment | 2020 |
Idiopathic nonhistaminergic acquired angioedema in a patient with coronavirus disease 2019.
Topics: Adenosine Monophosphate; Adult; Alanine; Ampicillin; Angioedema; Betacoronavirus; Coronavirus Infections; COVID-19; Diabetes Mellitus, Type 2; Female; Humans; Hydroxychloroquine; Hyperlipidemias; Intubation, Intratracheal; Obesity; Pandemics; Pneumonia, Viral; Respiration, Artificial; Respiratory Insufficiency; SARS-CoV-2; Treatment Outcome | 2020 |
Remdesivir for the Treatment of Covid-19 - Preliminary Report.
Topics: Adenosine Monophosphate; Alanine; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Humans; Pandemics; Pneumonia, Viral; SARS-CoV-2 | 2020 |
Remdesivir for the Treatment of Covid-19 - Preliminary Report.
Topics: Adenosine Monophosphate; Alanine; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Humans; Pandemics; Pneumonia, Viral; SARS-CoV-2 | 2020 |
Remdesivir for the Treatment of Covid-19 - Preliminary Report.
Topics: Adenosine Monophosphate; Alanine; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Humans; Pandemics; Pneumonia, Viral; SARS-CoV-2 | 2020 |
Remdesivir for the Treatment of Covid-19 - Preliminary Report.
Topics: Adenosine Monophosphate; Alanine; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Humans; Pandemics; Pneumonia, Viral; SARS-CoV-2 | 2020 |
Remdesivir for the Treatment of Covid-19 - Preliminary Report. Reply.
Topics: Adenosine Monophosphate; Alanine; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Humans; Pandemics; Pneumonia, Viral; SARS-CoV-2 | 2020 |
Remdesivir during induction chemotherapy for newly diagnosed paediatric acute lymphoblastic leukaemia with concomitant SARS-CoV-2 infection.
Topics: Adenosine Monophosphate; Alanine; Betacoronavirus; Child, Preschool; Coronavirus Infections; COVID-19; Humans; Induction Chemotherapy; Male; Pandemics; Pneumonia, Viral; Precursor Cell Lymphoblastic Leukemia-Lymphoma; SARS-CoV-2 | 2020 |
COVID-19 Therapeutics: Making Sense of It All.
Topics: Adenosine Monophosphate; Adult; Alanine; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Double-Blind Method; Humans; Pandemics; Pneumonia, Viral; SARS-CoV-2 | 2020 |
In vitro evaluation of antiviral activity of single and combined repurposable drugs against SARS-CoV-2.
Topics: Adenosine Monophosphate; Alanine; Animals; Antiviral Agents; Berberine; Betacoronavirus; Chlorocebus aethiops; Chloroquine; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Cyclosporine; Drug Antagonism; Drug Combinations; Drug Repositioning; Drug Synergism; Humans; Indoles; Lopinavir; Pandemics; Pneumonia, Viral; SARS-CoV-2; Vero Cells | 2020 |
Remdesivir improved time to recovery in adults hospitalized with COVID-19 and lower respiratory tract involvement.
Topics: Adenosine Monophosphate; Adolescent; Adult; Alanine; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; Female; Humans; Male; Middle Aged; Multicenter Studies as Topic; Pandemics; Pneumonia, Viral; Randomized Controlled Trials as Topic; SARS-CoV-2 | 2020 |
Using "old" medications to fight new COVID-19: Re-purposing with a purpose.
Topics: Adenosine Monophosphate; Alanine; Angiotensin-Converting Enzyme Inhibitors; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; Dexamethasone; Diabetes Mellitus; Drug Repositioning; Host-Pathogen Interactions; Humans; Hydroxychloroquine; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Hypertension; Hypolipidemic Agents; Obesity; Pandemics; Pneumonia, Viral; SARS-CoV-2 | 2020 |
Utilization of COVID-19 Treatments and Clinical Outcomes among Patients with Cancer: A COVID-19 and Cancer Consortium (CCC19) Cohort Study.
Topics: Adenosine Monophosphate; Age Factors; Aged; Alanine; Betacoronavirus; Clinical Decision-Making; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Drug Therapy, Combination; Drug Utilization; Follow-Up Studies; Glucocorticoids; Healthcare Disparities; Hospital Mortality; Humans; Hydroxychloroquine; Male; Middle Aged; Neoplasms; Pandemics; Pneumonia, Viral; Risk Factors; SARS-CoV-2; Severity of Illness Index; Sex Factors; Treatment Outcome; United States | 2020 |
Persistent COVID-19 in an Immunocompromised Patient Temporarily Responsive to Two Courses of Remdesivir Therapy.
Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Fever; Humans; Immunocompromised Host; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Middle Aged; Pandemics; Pneumonia, Viral; SARS-CoV-2; Severe Acute Respiratory Syndrome; Time Factors; Treatment Outcome | 2020 |
Discovery of SARS-CoV-2 antiviral drugs through large-scale compound repurposing.
Topics: Adenosine Monophosphate; Alanine; Alveolar Epithelial Cells; Antiviral Agents; Betacoronavirus; Cell Line; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Cysteine Proteinase Inhibitors; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Drug Repositioning; Drug Synergism; Gene Expression Regulation; Humans; Hydrazones; Induced Pluripotent Stem Cells; Models, Biological; Morpholines; Pandemics; Pneumonia, Viral; Pyrimidines; Reproducibility of Results; SARS-CoV-2; Small Molecule Libraries; Triazines; Virus Internalization; Virus Replication | 2020 |
Interactions Between Remdesivir, Ribavirin, Favipiravir, Galidesivir, Hydroxychloroquine and Chloroquine with Fragment Molecular of the COVID-19 Main Protease with Inhibitor N3 Complex (PDB ID:6LU7) Using Molecular Docking.
Topics: Adenine; Adenosine; Adenosine Monophosphate; Alanine; Amides; Antiviral Agents; Betacoronavirus; Binding Sites; Chloroquine; Coronavirus 3C Proteases; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Cysteine Endopeptidases; Drug Interactions; Humans; Hydrogen Bonding; Hydroxychloroquine; Ligands; Molecular Docking Simulation; Nanotechnology; Pandemics; Pneumonia, Viral; Protease Inhibitors; Pyrazines; Pyrrolidines; Ribavirin; SARS-CoV-2; Static Electricity; Viral Nonstructural Proteins | 2020 |
Hepatic Disorders With the Use of Remdesivir for Coronavirus 2019.
Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Betacoronavirus; Chemical and Drug Induced Liver Injury; Coronavirus Infections; COVID-19; Europe; Female; Humans; Incidence; Male; Middle Aged; Pandemics; Pneumonia, Viral; SARS-CoV-2; United States | 2020 |
Liver injury in remdesivir-treated COVID-19 patients.
Topics: Adenosine Monophosphate; Administration, Intravenous; Adult; Aged; Alanine; Antiviral Agents; Betacoronavirus; Chemical and Drug Induced Liver Injury; Compassionate Use Trials; Coronavirus Infections; COVID-19; Critical Illness; Dose-Response Relationship, Drug; Drug Monitoring; Humans; Italy; Liver Function Tests; Male; Middle Aged; Pandemics; Pneumonia, Viral; SARS-CoV-2; Treatment Outcome | 2020 |
[COVID-19: a cardiological point-of-view].
Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Arteritis; Betacoronavirus; Cardiovascular Diseases; Coronavirus Infections; COVID-19; Humans; Pandemics; Pneumonia, Viral; SARS-CoV-2; Venous Thrombosis | 2020 |
Remdesivir for severe covid-19: a clinical practice guideline.
Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Guideline Adherence; Humans; Length of Stay; Network Meta-Analysis; Pandemics; Pneumonia, Viral; Randomized Controlled Trials as Topic; Respiration, Artificial; SARS-CoV-2; Severity of Illness Index; Time Factors; Treatment Outcome | 2020 |
Communicating Science in the Time of a Pandemic.
Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Betacoronavirus; Communication; Coronavirus Infections; COVID-19; Dexamethasone; Glucocorticoids; Humans; Hydroxychloroquine; Journalism, Medical; Pandemics; Peer Review, Research; Pneumonia, Viral; SARS-CoV-2; Science | 2020 |
Mouse-adapted SARS-CoV-2 replicates efficiently in the upper and lower respiratory tract of BALB/c and C57BL/6J mice.
Topics: Adaptation, Physiological; Adenosine Monophosphate; Administration, Intranasal; Alanine; Animals; Betacoronavirus; Chlorocebus aethiops; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Disease Models, Animal; Female; Host Specificity; Lung; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mutation, Missense; Nasal Mucosa; Pandemics; Pneumonia, Viral; RNA, Viral; SARS-CoV-2; Turbinates; Vero Cells; Viral Load; Virus Replication | 2020 |
BET 1: The role of remdesivir in COVID-19 infection.
Topics: Adenosine Monophosphate; Adult; Alanine; Antiviral Agents; Betacoronavirus; Clinical Trials as Topic; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Evidence-Based Practice; Female; Humans; Male; Pandemics; Pneumonia, Viral; SARS-CoV-2; Treatment Outcome | 2020 |
Treatments for COVID-19: where are we now?
Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Humans; Immunologic Factors; Pandemics; Pneumonia, Viral; SARS-CoV-2 | 2020 |
Were it business opportunities or hidden risks: Observations on clinical trials and marketing authorizations of Gilead Science's remdesivir in China.
Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; China; Clinical Trials as Topic; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Drug Approval; Drug Industry; Drugs, Generic; Economic Competition; Humans; Pandemics; Pneumonia, Viral | 2020 |
Use of remdesivir for pregnant patients with severe novel coronavirus disease 2019.
Topics: Adenosine Monophosphate; Adult; Alanine; Antiviral Agents; Coronavirus Infections; COVID-19; Female; Humans; Pandemics; Pneumonia, Viral; Pregnancy; Pregnancy Complications, Infectious; Treatment Outcome | 2020 |
Experts Discuss COVID-19-Remdesivir, Vaccines, and More.
Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Betacoronavirus; Contact Tracing; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; COVID-19 Vaccines; Dexamethasone; Disease Transmission, Infectious; Humans; Masks; Pandemics; Pneumonia, Viral; SARS-CoV-2; Viral Vaccines | 2020 |
Joint analysis of duration of ventilation, length of intensive care, and mortality of COVID-19 patients: a multistate approach.
Topics: Adenosine Monophosphate; Alanine; Algorithms; Antiviral Agents; Betacoronavirus; Cohort Studies; Compassionate Use Trials; Coronavirus Infections; COVID-19; Critical Care; Humans; Intensive Care Units; Length of Stay; Models, Theoretical; Pandemics; Pneumonia, Viral; Respiration, Artificial; SARS-CoV-2; Survival Analysis; Survival Rate; Time Factors | 2020 |
A Chemoenzymatic Synthesis of the (
Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Betacoronavirus; Caulobacteraceae; Coronavirus Infections; COVID-19; Humans; Molecular Structure; Pandemics; Phosphoric Triester Hydrolases; Pneumonia, Viral; RNA-Dependent RNA Polymerase; SARS-CoV-2; Virus Replication | 2020 |
Clinical outcomes of hospitalised patients with COVID-19 and chronic inflammatory and autoimmune rheumatic diseases: a multicentric matched cohort study.
Topics: Adenosine Monophosphate; Age Factors; Aged; Alanine; Antiviral Agents; Arthritis, Psoriatic; Arthritis, Rheumatoid; Betacoronavirus; Cardiovascular Diseases; Case-Control Studies; Cohort Studies; Comorbidity; Connective Tissue Diseases; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Drug Combinations; Female; Glucocorticoids; Hospitalization; Humans; Hydroxychloroquine; Immunosuppressive Agents; Logistic Models; Lopinavir; Lupus Erythematosus, Systemic; Male; Middle Aged; Obesity; Pandemics; Pneumonia, Viral; Polymyalgia Rheumatica; Prognosis; Rheumatic Diseases; Risk Factors; Ritonavir; SARS-CoV-2; Severity of Illness Index; Sex Factors; Sjogren's Syndrome; Spondylarthropathies | 2020 |
Policy Implications of the Orphan Drug Designation for Remdesivir to Treat COVID-19.
Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Humans; Orphan Drug Production; Pandemics; Pneumonia, Viral; SARS-CoV-2; United States; United States Food and Drug Administration | 2020 |
Bilateral posterior cerebral artery territory infarction in a SARS-Cov-2 infected patient: discussion about an unusual case.
Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Diagnosis, Differential; Fatal Outcome; Host-Pathogen Interactions; Humans; Infarction, Posterior Cerebral Artery; Male; Middle Aged; Pandemics; Pneumonia, Viral; Predictive Value of Tests; Risk Factors; SARS-CoV-2; Thrombolytic Therapy; Treatment Outcome | 2020 |
Efficacy of Remdesivir in COVID-19.
Topics: Adenosine Monophosphate; Alanine; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Humans; Pandemics; Pneumonia, Viral; SARS-CoV-2 | 2020 |
Effectiveness of remdesivir in patients with COVID-19 under mechanical ventilation in an Italian ICU.
Topics: Adenosine Monophosphate; Aged; Alanine; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; Female; Follow-Up Studies; Humans; Intensive Care Units; Italy; Male; Middle Aged; Pandemics; Pneumonia, Viral; Respiration, Artificial; Retrospective Studies; SARS-CoV-2; Treatment Outcome | 2020 |
Allocating Remdesivir Under Scarcity: Social Justice or More Systemic Racism.
Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; Healthcare Disparities; Humans; Pandemics; Pneumonia, Viral; Racism; SARS-CoV-2; Social Justice; United States | 2020 |
Antiviral treatment for COVID-19: the evidence supporting remdesivir.
Topics: Adenosine Monophosphate; Administration, Intravenous; Alanine; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; Female; Humans; Male; Middle Aged; Pandemics; Pneumonia, Viral; Randomized Controlled Trials as Topic; SARS-CoV-2 | 2020 |
Data Monitoring for the Chinese Clinical Trials of Remdesivir in Treating Patients with COVID-19 During the Pandemic Crisis.
Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Betacoronavirus; China; Clinical Trials Data Monitoring Committees; Clinical Trials, Phase III as Topic; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Data Accuracy; Host Microbial Interactions; Humans; Pandemics; Pneumonia, Viral; Randomized Controlled Trials as Topic; Research Design; SARS-CoV-2; Time Factors; Treatment Outcome | 2020 |
Removal of Remdesivir's Metabolite GS-441524 by Hemodialysis in a Double Lung Transplant Recipient with COVID-19.
Topics: Adenosine; Adenosine Monophosphate; Alanine; Antiviral Agents; beta-Cyclodextrins; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Drug Interactions; Furans; Humans; Intensive Care Units; Lung Transplantation; Multiple Organ Failure; Pandemics; Pneumonia, Viral; Pyrroles; Renal Dialysis; SARS-CoV-2; Transplant Recipients; Triazines | 2020 |
It Ain't Over Till It's Over: The Triple Threat of COVID-19, TB, and HIV.
Topics: Adenosine Monophosphate; Alanine; Antitubercular Agents; Antiviral Agents; Betacoronavirus; Coinfection; Comorbidity; Coronavirus Infections; COVID-19; Drug Interactions; HIV Infections; HIV-1; Humans; Mycobacterium tuberculosis; Pandemics; Pneumonia, Viral; Prevalence; Rifampin; SARS-CoV-2; Survival Analysis; Tuberculosis, Pulmonary; United States | 2020 |
Successful treatment with Remdesivir and corticosteroids in a patient with COVID-19-associated pneumonia: A case report.
Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Cytokine Release Syndrome; Glucocorticoids; Humans; Male; Methylprednisolone; Middle Aged; Pandemics; Pneumonia, Viral; SARS-CoV-2 | 2020 |
Remdesivir and COVID-19: What are the implications for Africa?
Topics: Adenosine Monophosphate; Africa; Alanine; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Double-Blind Method; Humans; Pandemics; Pneumonia, Viral; SARS-CoV-2 | 2020 |
Quantifying the effect of remdesivir in rhesus macaques infected with SARS-CoV-2.
Topics: Adenosine Monophosphate; Alanine; Animals; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; Disease Models, Animal; Drug Administration Schedule; Humans; Inflammation; Macaca mulatta; Models, Statistical; Pandemics; Pneumonia, Viral; SARS-CoV-2; Viral Load; Virus Replication | 2020 |
Remdesivir, a remedy or a ripple in severe COVID-19?
Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Humans; Pandemics; Pneumonia, Viral; Randomized Controlled Trials as Topic; Severity of Illness Index; Treatment Outcome | 2020 |
Kidney Transplantation and COVID-19.
Topics: Adenosine Monophosphate; Alanine; Antibodies, Monoclonal, Humanized; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Transplantation; Pandemics; Pneumonia, Viral; SARS-CoV-2; Transplant Recipients | 2020 |
COVID-19 convalescent plasma clears SARS-CoV-2 refractory to remdesivir in an infant with congenital heart disease.
Topics: Adenosine Monophosphate; Alanine; Antibodies, Neutralizing; Antiviral Agents; Coronavirus Infections; COVID-19; Down Syndrome; Female; Heart Diseases; Humans; Immunization, Passive; Infant; Pandemics; Pneumonia, Viral; Respiratory Insufficiency | 2020 |
COVID-19: Rescue by transcriptional inhibition.
Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; Cytidine; Humans; Hydroxylamines; Pandemics; Pneumonia, Viral; Ribonucleosides; RNA-Dependent RNA Polymerase; SARS-CoV-2; Transcription, Genetic | 2020 |
Pulmonary administration of remdesivir in the treatment of COVID-19.
Topics: Adenosine Monophosphate; Alanine; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Humans; Pandemics; Pneumonia, Viral; SARS-CoV-2 | 2020 |
Recognition of Potential COVID-19 Drug Treatments through the Study of Existing Protein-Drug and Protein-Protein Structures: An Analysis of Kinetically Active Residues.
Topics: Adenosine Monophosphate; Alanine; Angiotensin-Converting Enzyme 2; Antibodies, Viral; Antigen-Antibody Reactions; Antiviral Agents; Betacoronavirus; Binding Sites; Chloroquine; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Drug Repositioning; Eflornithine; Humans; Hydrophobic and Hydrophilic Interactions; Ivermectin; L-Lactate Dehydrogenase; Models, Molecular; Molecular Docking Simulation; Pandemics; Peptidyl-Dipeptidase A; Pneumonia, Viral; Proline; Protein Binding; Protein Conformation; Protein Interaction Mapping; Receptors, Glycine; Saposins; SARS-CoV-2; Sofosbuvir; Spike Glycoprotein, Coronavirus; Structure-Activity Relationship | 2020 |
Evaluation of the potency of FDA-approved drugs on wild type and mutant SARS-CoV-2 helicase (Nsp13).
Topics: Adenosine Monophosphate; Amino Acid Sequence; Betacoronavirus; Binding Sites; Computer Simulation; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Drug Approval; Drug Repositioning; Enzyme Inhibitors; Folic Acid; Genome, Viral; Glucosides; Humans; Methyltransferases; Molecular Docking Simulation; Mutation; Pandemics; Pneumonia, Viral; RNA Helicases; SARS-CoV-2; Stilbenes; Vidarabine; Viral Nonstructural Proteins | 2020 |
Compassionate Drug Use - Time Arising for a New Law in Bulgaria in the Era of COVID-19.
Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Betacoronavirus; Bulgaria; Compassionate Use Trials; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Drugs, Investigational; Health Policy; Humans; Pandemics; Pneumonia, Viral; SARS-CoV-2 | 2020 |
Remdesivir and COVID-19.
Topics: Adenosine Monophosphate; Adult; Alanine; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Double-Blind Method; Humans; Pandemics; Pneumonia, Viral; SARS-CoV-2 | 2020 |
Remdesivir and COVID-19.
Topics: Adenosine Monophosphate; Adult; Alanine; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Double-Blind Method; Humans; Pandemics; Pneumonia, Viral; SARS-CoV-2 | 2020 |
Remdesivir and COVID-19.
Topics: Adenosine Monophosphate; Adult; Alanine; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Double-Blind Method; Humans; Pandemics; Pneumonia, Viral; SARS-CoV-2 | 2020 |
Remdesivir and COVID-19 - Authors' reply.
Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Humans; Pandemics; Pneumonia, Viral; Ribonucleotides; SARS-CoV-2 | 2020 |
Sofosbuvir terminated RNA is more resistant to SARS-CoV-2 proofreader than RNA terminated by Remdesivir.
Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Betacoronavirus; Coronavirus Infections; Coronavirus RNA-Dependent RNA Polymerase; COVID-19; Drug Discovery; Drug Repositioning; Exonucleases; Hepacivirus; Hepatitis C; Humans; Pandemics; Pneumonia, Viral; Prodrugs; RNA-Dependent RNA Polymerase; RNA, Viral; SARS-CoV-2; Sofosbuvir; Viral Nonstructural Proteins; Virus Replication | 2020 |
Audio Interview: Covid-19 and the President.
Topics: Adenosine Monophosphate; Alanine; Antibodies, Monoclonal; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Serotherapy; Dexamethasone; Drug Administration Schedule; Drug Therapy, Combination; Federal Government; Glucocorticoids; Government Employees; HIV Protease Inhibitors; Humans; Hypoxia; Immunization, Passive; Lopinavir; Oxygen Inhalation Therapy; Pandemics; Patient Acuity; Pneumonia, Viral; Risk Assessment; SARS-CoV-2; United States; Virus Replication | 2020 |
Management and outcomes of patients hospitalized with severe COVID-19 at a tertiary care center in midwestern United States.
Topics: Adenosine Monophosphate; Alanine; Antibodies, Monoclonal, Humanized; Anticoagulants; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; COVID-19 Serotherapy; Critical Care; Glucocorticoids; Hospitalization; Humans; Immunization, Passive; Midwestern United States; Pandemics; Pneumonia, Viral; Respiration, Artificial; Retrospective Studies; SARS-CoV-2; Tertiary Care Centers; Tertiary Healthcare | 2020 |
Cyanoamidine Cyclization Approach to Remdesivir's Nucleobase.
Topics: Adenosine Monophosphate; Alanine; Amidines; Antiviral Agents; Chemistry Techniques, Synthetic; Coronavirus Infections; COVID-19; Cyclization; Pandemics; Pneumonia, Viral | 2020 |
Exploring RdRp-remdesivir interactions to screen RdRp inhibitors for the management of novel coronavirus 2019-nCoV.
Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Molecular Docking Simulation; Pandemics; Pneumonia, Viral; Quantitative Structure-Activity Relationship; RNA-Dependent RNA Polymerase; SARS-CoV-2; Viral Proteins | 2020 |
Identification of potential COVID-19 main protease inhibitors using structure-based pharmacophore approach, molecular docking and repurposing studies.
Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Crystallography, X-Ray; Drug Discovery; Drug Repositioning; Humans; Models, Chemical; Molecular Docking Simulation; Molecular Structure; Pandemics; Pneumonia, Viral; Protease Inhibitors; Structure-Activity Relationship | 2021 |
Impact of Trump's Promotion of Unproven COVID-19 Treatments and Subsequent Internet Trends: Observational Study.
Topics: Adenosine Monophosphate; Alanine; Azithromycin; Chloroquine; Communication; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Federal Government; Fraud; Humans; Hydroxychloroquine; Internet; Language; Mass Media; Pandemics; Pneumonia, Viral; Public Health; United States | 2020 |
Why do COVID death rates seem to be falling?
Topics: Adenosine Monophosphate; Age Distribution; Age Factors; Aged; Aged, 80 and over; Alanine; Antibodies, Monoclonal, Humanized; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Serotherapy; Dexamethasone; Humans; Immunization, Passive; Intensive Care Units; Oxygen; Pandemics; Pneumonia, Viral; Respiratory Distress Syndrome; SARS-CoV-2; Time Factors; Ventilators, Mechanical | 2020 |
Broncho-alveolar inflammation in COVID-19 patients: a correlation with clinical outcome.
Topics: Adenosine Monophosphate; Adrenal Cortex Hormones; Aged; Alanine; Antibodies, Monoclonal, Humanized; Antiviral Agents; Betacoronavirus; Bronchoalveolar Lavage; Bronchoalveolar Lavage Fluid; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Drug Combinations; Female; Humans; Hydroxychloroquine; Inflammation; Intensive Care Units; Interleukin-10; Interleukin-6; Interleukin-8; Italy; Leukocytes; Leukocytes, Mononuclear; Lopinavir; Lung; Lymphocytes; Macrophages, Alveolar; Male; Microscopy, Electron, Transmission; Middle Aged; Neutrophils; Pandemics; Pneumonia, Viral; Prognosis; Prospective Studies; Respiration, Artificial; Ritonavir; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Survival Rate; Virion | 2020 |
Audio Interview: What the U.S. Response to Covid-19 Looks Like Today.
Topics: Adenosine Monophosphate; Alanine; Antibodies, Monoclonal; Antiviral Agents; Asymptomatic Diseases; Betacoronavirus; Clinical Laboratory Techniques; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; COVID-19 Testing; COVID-19 Vaccines; Dexamethasone; Disease Transmission, Infectious; Drug Development; Humans; Pandemics; Pneumonia, Viral; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Treatment Outcome; Viral Vaccines | 2020 |
[Nursing Experience Caring for a COVID-19 Patient With Hearing Loss].
Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Communication; Coronavirus Infections; COVID-19; Hearing Loss; Humans; Male; Pandemics; Patient-Centered Care; Pneumonia, Viral; SARS-CoV-2; Social Isolation; Taiwan; Treatment Outcome | 2020 |
Severe Acute Respiratory Syndrome Coronavirus-2 Pneumonia in a Newborn Treated With Remdesivir and Coronavirus Disease 2019 Convalescent Plasma.
Topics: Adenosine Monophosphate; Adolescent; Alanine; Antiviral Agents; COVID-19; COVID-19 Serotherapy; Female; Humans; Immunization, Passive; Infant, Newborn; Infectious Disease Transmission, Vertical; Pneumonia, Viral; SARS-CoV-2 | 2021 |
Remdesivir for COVID-19 pneumonia: still undecided, but it might all be about adequate timing.
Topics: Adenosine Monophosphate; Airway Management; Alanine; Antiviral Agents; COVID-19; COVID-19 Drug Treatment; Disease Progression; Humans; Hypoxia; Mortality; Patient Selection; Pneumonia, Viral; Randomized Controlled Trials as Topic; Respiratory Insufficiency; SARS-CoV-2; Time-to-Treatment; Treatment Outcome | 2021 |
Should Remdesivir Be Used for the Treatment of Patients With COVID-19? Rapid, Living Practice Points From the American College of Physicians (Version 2).
Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; COVID-19 Drug Treatment; Humans; Pneumonia, Viral; SARS-CoV-2 | 2021 |
A case report of COVID-19 in refractory myasthenia: Outcome with remdesivir and dexamethasone.
Topics: Adenosine Monophosphate; Aged; Alanine; Antiviral Agents; COVID-19 Drug Treatment; Dexamethasone; Drug Therapy, Combination; Glucocorticoids; Humans; Male; Myasthenia Gravis; Plasmapheresis; Pneumonia, Viral; SARS-CoV-2 | 2021 |
Dramatic Response to Convalescent Hyperimmune Plasma in Association With an Extended Course of Remdesivir in 4 B Cell-Depleted Non-Hodgkin Lymphoma Patients With SARS-Cov-2 Pneumonia After Rituximab Therapy.
Topics: Adenosine Monophosphate; Alanine; B-Lymphocytes; Combined Modality Therapy; COVID-19; COVID-19 Drug Treatment; COVID-19 Serotherapy; Drug Administration Schedule; Humans; Immunization, Passive; Immunocompromised Host; Immunosuppressive Agents; Italy; Lymphoma, Non-Hodgkin; Lymphopenia; Male; Middle Aged; Pneumonia, Viral; Rituximab; SARS-CoV-2; Treatment Outcome | 2021 |